JP2013253041A - Method for producing compound - Google Patents

Method for producing compound Download PDF

Info

Publication number
JP2013253041A
JP2013253041A JP2012129727A JP2012129727A JP2013253041A JP 2013253041 A JP2013253041 A JP 2013253041A JP 2012129727 A JP2012129727 A JP 2012129727A JP 2012129727 A JP2012129727 A JP 2012129727A JP 2013253041 A JP2013253041 A JP 2013253041A
Authority
JP
Japan
Prior art keywords
group
oco
coo
compound
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012129727A
Other languages
Japanese (ja)
Other versions
JP5988087B2 (en
Inventor
Masahiro Horiguchi
雅弘 堀口
Yoshio Aoki
良夫 青木
Masanao Hayashi
正直 林
Tetsuo Kusumoto
哲生 楠本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DIC Corp
Original Assignee
DIC Corp
Dainippon Ink and Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DIC Corp, Dainippon Ink and Chemicals Co Ltd filed Critical DIC Corp
Priority to JP2012129727A priority Critical patent/JP5988087B2/en
Priority to KR1020130064450A priority patent/KR20130137548A/en
Priority to CN201310224992.1A priority patent/CN103483117B/en
Publication of JP2013253041A publication Critical patent/JP2013253041A/en
Application granted granted Critical
Publication of JP5988087B2 publication Critical patent/JP5988087B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B41/00Formation or introduction of functional groups containing oxygen
    • C07B41/12Formation or introduction of functional groups containing oxygen of carboxylic acid ester groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B41/00Formation or introduction of functional groups containing oxygen
    • C07B41/08Formation or introduction of functional groups containing oxygen of carboxyl groups or salts, halides or anhydrides thereof
    • C07B41/10Salts, halides or anhydrides of carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72Hydrazones
    • C07C251/88Hydrazones having also the other nitrogen atom doubly-bound to a carbon atom, e.g. azines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • C07C381/14Compounds containing a carbon atom having four bonds to hetero atoms with a double bond to one hetero atom and at least one bond to a sulfur atom further doubly-bound to oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/54Preparation of carboxylic acid anhydrides
    • C07C51/56Preparation of carboxylic acid anhydrides from organic acids, their salts, their esters or their halides, e.g. by carboxylation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/12Preparation of carboxylic acid esters from asymmetrical anhydrides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/92Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups

Abstract

PROBLEM TO BE SOLVED: To provide a method for producing a compound having an ester bond and/or amide bond, with a small content of impurities in high yield; and to provide a high purity compound obtained by the method.SOLUTION: There is provided a method for producing a mixed acid anhydride (4) by adding a compound (1) having at least one carboxy group and a base (2) simultaneously without mixing in advance to an acid halide compound (3) to react them. Also a method for producing an ester compound and/or amide compound (6) is provided which comprises: adding a compound (1) having at least one carboxy group and a base (2) simultaneously without mixing in advance to an acid halide compound (3) to react them to produce a mixed acid anhydride (4); and thereafter reacting with a compound (5) having at least one group selected from a hydroxy group, mercapto group and/or amino group.

Description

本発明はエステル結合又は/及びアミド結合を有する化合物の製造法、当該製造法により得られた化合物を含有する組成物及び当該組成物を用いた医薬品、農薬、液晶材料、ポリマー、樹脂、顔料、染料、化粧品、食品、インキ、粘着剤、接着剤、印刷物、光学異方体、表示素子及び電子デバイスに関する。   The present invention relates to a method for producing a compound having an ester bond or / and an amide bond, a composition containing a compound obtained by the production method, a pharmaceutical, an agrochemical, a liquid crystal material, a polymer, a resin, a pigment using the composition, The present invention relates to dyes, cosmetics, foods, inks, pressure-sensitive adhesives, adhesives, printed materials, optical anisotropic bodies, display elements, and electronic devices.

エステル結合又は/及びアミド結合を有する化合物は、合成樹脂、液晶材料、医薬品、農薬、顔料、染料、食品、合成繊維、プラスチック、添加剤又は化粧品を始めとする種々の用途に利用されている。いずれの用途においても、品質、安全性及び信頼性の観点からそれらの化合物は高純度であることが望まれる。また、収益性の観点からは収率良くそれらの化合物を製造することが重要である。   Compounds having an ester bond or / and an amide bond are used in various applications including synthetic resins, liquid crystal materials, pharmaceuticals, agricultural chemicals, pigments, dyes, foods, synthetic fibers, plastics, additives or cosmetics. In any application, those compounds are desired to have high purity from the viewpoints of quality, safety and reliability. From the viewpoint of profitability, it is important to produce those compounds with good yield.

特に電子材料分野においては使用する化合物の純度が高いことが望まれる。例えば、電子材料分野における光学異方体の分野に重合性液晶材料が使用されている。光学異方体は重合性液晶組成物を液晶状態で配列させた後、重合させることにより、均一な配向を有するフィルムや樹脂として得ることができる。このようにして作製したフィルムや樹脂は、液晶ディスプレイに必要な偏光板、位相差板などに使用することができる。多くの場合、要求される光学特性、重合速度、溶解性、融点、ガラス転移温度、フィルムの透明性、機械的強度、表面硬度、耐熱性及び耐光性を満たすために、2種類以上の重合性化合物からなる組成物が使用される。しかしながら、組成物を構成する重合性化合物に不純物が混入していると、作製したフィルムや樹脂にムラや変色等の問題が発生することがある。ムラや変色のあるフィルムを例えば液晶ディスプレイ用の光学フィルムとして使用すると、画面の明るさが不均一になったり、ディスプレイの色味が不自然になったりするため、液晶ディスプレイの表示品質を大きく低下させてしまう。このため、電子材料分野に使用される場合にはppmオーダーでの不純物の管理が要求される。   In particular, in the field of electronic materials, it is desired that the compound used has a high purity. For example, polymerizable liquid crystal materials are used in the field of optical anisotropic bodies in the field of electronic materials. The optical anisotropic body can be obtained as a film or a resin having a uniform orientation by aligning the polymerizable liquid crystal composition in a liquid crystal state and then polymerizing it. The film and resin thus produced can be used for polarizing plates, retardation plates and the like necessary for liquid crystal displays. In many cases, two or more types of polymerizability are required to satisfy the required optical properties, polymerization rate, solubility, melting point, glass transition temperature, film transparency, mechanical strength, surface hardness, heat resistance and light resistance. Compositions consisting of compounds are used. However, if impurities are mixed in the polymerizable compound constituting the composition, problems such as unevenness and discoloration may occur in the produced film or resin. If a film with unevenness or discoloration is used as an optical film for a liquid crystal display, for example, the brightness of the screen will be uneven and the color of the display will become unnatural. I will let you. For this reason, when used in the field of electronic materials, management of impurities on the order of ppm is required.

エステル結合又は/及びアミド結合を有する化合物の製造方法としては種々の方法が知られているが、カルボキシル基を有する前駆体の混合酸無水物と、水酸基、アミノ基又は/及びメルカプト基を有する前駆体とを塩基存在下反応させることによる製造方法は、反応条件が穏和で、用いる原料が安価であることから広く用いられている。しかしながら、当該製造方法を公知の反応条件によって実施した場合、目的の化合物への転換率が低いために未反応の原料を除去する精製工程が必要となり、単離収率が低くなってしまったり、目的の化合物の純度が低下してしまったりする問題があった。また、精製後においても未反応の原料や副生成物が残留する問題があった。このようなエステル結合又は/及びアミド結合を有する化合物を含有する重合性液晶組成物を使用して作製したフィルムは、ムラが生じたり、重合させた後若しくは完全硬化のためにポストベーク処理を行った後に変色が起こったりしてしまい、そのようなフィルムを例えば液晶ディスプレイの部材として使用した場合、製品の品質を大きく低下させてしまう問題があった。そのため、エステル結合又は/及びアミド結合を有する化合物を収率良く高純度で得ることのできる製造方法が求められていた。   Various methods are known as a method for producing a compound having an ester bond or / and an amide bond, and a mixed acid anhydride of a precursor having a carboxyl group and a precursor having a hydroxyl group, an amino group and / or a mercapto group. A production method by reacting a product with a base in the presence of a base is widely used because the reaction conditions are mild and the raw materials used are inexpensive. However, when the production method is carried out under known reaction conditions, a purification step for removing unreacted raw materials is necessary because the conversion rate to the target compound is low, and the isolation yield becomes low. There has been a problem that the purity of the target compound is lowered. Further, there is a problem that unreacted raw materials and by-products remain even after purification. Films prepared using a polymerizable liquid crystal composition containing a compound having such an ester bond or / and an amide bond are uneven, subjected to post-baking treatment after polymerization or for complete curing. Then, discoloration occurs, and when such a film is used as a member of a liquid crystal display, for example, there is a problem that the quality of the product is greatly deteriorated. Therefore, a production method capable of obtaining a compound having an ester bond or / and an amide bond with high yield and high purity has been demanded.

特開2011−057635号公報JP 2011-057635 A WO2009−122868A1号公報WO2009-122868A1 特開平9−104642号公報Japanese Patent Laid-Open No. 9-104642

The Journal of Organic Chemistry、1991、56(1)、405−411The Journal of Organic Chemistry, 1991, 56 (1), 405-411.

本願発明が解決しようとする課題は、高収率かつ不純物含有量の少ないエステル結合又は/及びアミド結合を有する化合物の製造方法及び、当該製造方法により得られる高純度化合物を提供することである。   The problem to be solved by the present invention is to provide a method for producing a compound having an ester bond or / and an amide bond with a high yield and a low impurity content, and a high-purity compound obtained by the production method.

少なくとも一つのカルボキシル基を有する化合物と、塩基とを予め混合すること無く、同時に酸ハロゲン化合物に対し加え反応させることを特徴とする製造方法及び、当該製造方法により得られる高純度化合物を提供し、更に当該高純度化合物を中間体とする化合物及びその製造方法並びに、当該高純度化合物を使用した高純度組成物を提供する。   Provided is a production method characterized in that at least one compound having a carboxyl group and a base are added and reacted simultaneously with an acid halogen compound without mixing in advance, and a high-purity compound obtained by the production method, Furthermore, the compound which uses the said high purity compound as an intermediate, its manufacturing method, and the high purity composition which uses the said high purity compound are provided.

本願発明の製造方法により製造されるエステル結合又は/及びアミド結合を有する化合物は、高収率かつ不純物含有量が少ないことから、種々の組成物の構成部材として有用である。また、本願発明の製造方法により製造される化合物を含有する組成物は医薬品、農薬、液晶材料、ポリマー、樹脂、顔料、染料、化粧品、食品、インキ、粘着剤、接着剤、印刷物、光学異方体、表示素子及び電子デバイスの用途に有用である。   A compound having an ester bond or / and an amide bond produced by the production method of the present invention is useful as a component of various compositions because of its high yield and low impurity content. In addition, the composition containing the compound produced by the production method of the present invention is a pharmaceutical, agricultural chemical, liquid crystal material, polymer, resin, pigment, dye, cosmetics, food, ink, adhesive, adhesive, printed matter, optical anisotropic Useful for body, display element and electronic device applications.

少なくとも一つのカルボキシル基を有する化合物(1)と、塩基(2)とを予め混合すること無く、酸ハロゲン化合物(3)に対し同時に加え反応させる混合酸無水物(4)の製造方法を提供し併せて、少なくとも一つのカルボキシル基を有する化合物(1)と、塩基(2)とを予め混合すること無く、酸ハロゲン化合物(3)に対し同時に加え反応させ混合酸無水物(4)とした後に、少なくとも一つのヒドロキシル基、メルカプト基及び/又はアミノ基から選ばれる基を有する化合物(5)を更に反応させるエステル化合物及び/又はアミド化合物(6)の製造方法を提供する。   Provided is a method for producing a mixed acid anhydride (4) in which a compound (1) having at least one carboxyl group and a base (2) are added and reacted simultaneously with an acid halogen compound (3) without being mixed in advance. In addition, after the compound (1) having at least one carboxyl group and the base (2) are not mixed in advance, the acid halide compound (3) is simultaneously added and reacted to form a mixed acid anhydride (4). And a method for producing an ester compound and / or an amide compound (6), wherein the compound (5) having a group selected from at least one hydroxyl group, mercapto group and / or amino group is further reacted.

これらの実施形態において、少なくとも一つのカルボキシル基を有する化合物(1)は、芳香族カルボン酸又は脂肪族カルボン酸であることが好ましい。   In these embodiments, the compound (1) having at least one carboxyl group is preferably an aromatic carboxylic acid or an aliphatic carboxylic acid.

少なくとも一つのヒドロキシル基、メルカプト基及び/又はアミノ基から選ばれる基を有する化合物(5)は、アルコール類、フェノール類、チオール類、チオフェノール類、芳香族アミン及び又は脂肪族アミンであることが好ましい。   The compound (5) having a group selected from at least one hydroxyl group, mercapto group and / or amino group may be an alcohol, a phenol, a thiol, a thiophenol, an aromatic amine and / or an aliphatic amine. preferable.

酸ハロゲン化合物(3)は、スルホン酸ハロゲン化合物、カルボン酸ハロゲン化合物又はハロゲンギ酸エステル化合物であることが好ましい。   The acid halogen compound (3) is preferably a sulfonic acid halogen compound, a carboxylic acid halogen compound or a halogen formate compound.

塩基(2)は、アミン、アミド、カルバメート、イミド、スルホンアミド、グアニジン、ヒドラゾン、ヒドラジド、ヒドラジン、複素環アミン、それらの塩、金属アルコキシド又は金属水酸化物であることが好ましい。   The base (2) is preferably an amine, amide, carbamate, imide, sulfonamide, guanidine, hydrazone, hydrazide, hydrazine, heterocyclic amine, a salt thereof, a metal alkoxide or a metal hydroxide.

更に、少なくとも一つのカルボキシル基を有する化合物(1)は、下記一般式(I)で表される化合物であることが好ましい。   Furthermore, the compound (1) having at least one carboxyl group is preferably a compound represented by the following general formula (I).

Figure 2013253041
Figure 2013253041

(式中、Gは下記式(i) (In the formula, G 1 represents the following formula (i)

Figure 2013253041
Figure 2013253041

(式中、Aは各々独立して1,4−フェニレン基、ナフタレン−2,6−ジイル基、1,4−シクロヘキシレン基、1,4−シクロヘキセニレン基、1,4−ビシクロ[2.2.2]オクチレン基、デカヒドロナフタレン−2,6−ジイル基、1,2,3,4−テトラヒドロナフタレン−2,6−ジイル基、ピリジン−2,6−ジイル基、ピリミジン−2,5−ジイル基、1,3−ジオキサン−2,5−ジイル基又は単結合を表すが、これらの基は無置換又は、各々独立してハロゲン、シアノ基、ニトロ基、ペンタフルオロスルフラニル基又は炭素原子数1から10のアルキル基によって置換されていても良いが、このアルキル基は各々独立して1個以上の水素原子がフッ素原子又は塩素原子により置き換えられても良く、このアルキル基上の1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CY=CY−又は−C≡C−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基、フッ素原子、塩素原子又はシアノ基を表す。)に置換されても良く、AはP−Sp−で表される基(式中、Pは下記の式(P−1)から式(P−17) (In the formula, each A 1 is independently 1,4-phenylene group, naphthalene-2,6-diyl group, 1,4-cyclohexylene group, 1,4-cyclohexenylene group, 1,4-bicyclo [ 2.2.2] Octylene group, decahydronaphthalene-2,6-diyl group, 1,2,3,4-tetrahydronaphthalene-2,6-diyl group, pyridine-2,6-diyl group, pyrimidine-2 , 5-diyl group, 1,3-dioxane-2,5-diyl group or a single bond, these groups are unsubstituted or each independently halogen, cyano group, nitro group, pentafluorosulfuranyl The alkyl group may be substituted by a group or an alkyl group having 1 to 10 carbon atoms, and each of these alkyl groups may be independently substituted with one or more hydrogen atoms by fluorine atoms or chlorine atoms. The above one —CH 2 — or two or more non-adjacent —CH 2 — are each independently —O—, —S—, —CO—, —COO—, —OCO—, —CO—. S-, -S-CO-, -O-CO-O-, -CO-NH-, -NH-CO-, -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH—, —OCO—CH═CH—, —CY═CY— or —C≡C— (wherein Y is independently a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom) Or A 1 represents a group represented by P-Sp- (wherein P represents the following formula (P-1) to formula (P-17)).

Figure 2013253041
Figure 2013253041

から選ばれる基を表し、Spは1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CY=CY−又は−C≡C−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基、フッ素原子、塩素原子又はシアノ基を表す。)で置換されても良い炭素原子数1から20のアルキレン基又は単結合を表す。)によって置換されてもいても良く、Z11及びZ12は各々独立して−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CHCH−、−CHCF−、−CFCH−、−CFCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CY=CY−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基、フッ素原子、塩素原子又はシアノ基を表す。)、−C≡C−、−CH=N−、−N=CH−、−N=N−、−CH=N−N=CH−、炭素原子数1から20のアルキレン基又は単結合を表すが、このアルキレン基は各々独立して1個以上の水素原子がフッ素原子又は塩素原子により置き換えられても良く、このアルキレン基上の1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CY=CY−又は−C≡C−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基、フッ素原子、塩素原子又はシアノ基を表す。)に置き換えられても良く、m11は0から8の整数を表す。)を表し、R及びWは各々独立して水素原子、フッ素原子、塩素原子、臭素原子、ヨウ素原子、ペンタフルオロスルフラニル基、シアノ基、ニトロ基、炭素原子数1から20のアルキル基又はP−Sp−(式中、PはA中のPと同じ意味を表し、SpはAは中のSpと同じ意味を表す。ただし同一の基であっても異なる基であってもよい。)を表すが、このアルキル基は各々独立して1個以上の水素原子がフッ素原子又は塩素原子により置き換えられても良く、このアルキル基上の1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CY=CY−又は−C≡C−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基、フッ素原子、塩素原子又はシアノ基を表す。)に置き換えられても良いが、R及びWのうち少なくとも一方はカルボキシル基を表す。)
更に少なくとも一つのヒドロキシル基、メルカプト基及び/又はアミノ基から選ばれる基を有する化合物(5)は、下記式(II)で表される化合物であることが好ましい。
And Sp represents one —CH 2 — or two or more non-adjacent —CH 2 — each independently —O—, —S—, —CO—, —COO—, -OCO-, -CO-S-, -S-CO-, -O-CO-O-, -CO-NH-, -NH-CO-, -CH = CH-COO-, -CH = CH-OCO -, -COO-CH = CH-, -OCO-CH = CH-, -CY = CY- or -C≡C- (wherein Y is independently a hydrogen atom, an alkyl having 1 to 12 carbon atoms) Represents a group, a fluorine atom, a chlorine atom or a cyano group.) Represents an alkylene group having 1 to 20 carbon atoms which may be substituted, or a single bond. Z 11 and Z 12 are each independently —O—, —S—, —OCH 2 —, —CH 2 O—, —CO—, —COO—, —OCO—. , -CO-S -, - S -CO -, - O-CO-O -, - CO-NH -, - NH-CO -, - SCH 2 -, - CH 2 S -, - CF 2 O-, -OCF 2 -, - CF 2 S -, - SCF 2 -, - CH 2 CH 2 -, - CH 2 CF 2 -, - CF 2 CH 2 -, - CF 2 CF 2 -, - CH = CH-COO -, - CH = CH-OCO -, - COO-CH = CH -, - OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 - COO -, - CH 2 CH 2 -OCO -, - COO-CH 2 -, - OCO-CH 2 -, - CH 2 -C O -, - CH 2 -OCO - , - CY = CY- ( wherein, Y each independently represent a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom or a cyano group.) , —C≡C—, —CH═N—, —N═CH—, —N═N—, —CH═N—N═CH—, an alkylene group having 1 to 20 carbon atoms or a single bond. In this alkylene group, one or more hydrogen atoms may each independently be replaced by a fluorine atom or a chlorine atom, and one —CH 2 — or two or more — CH 2 — is independently —O—, —S—, —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—CO—O—, —CO. -NH-, -NH-CO-, -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH—, —OCO—CH═CH—, —CY═CY— or —C≡C— (wherein Y is independently a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom) Or represents a cyano group.), And m11 represents an integer of 0 to 8. R 1 and W 1 each independently represent a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a pentafluorosulfuranyl group, a cyano group, a nitro group, or an alkyl having 1 to 20 carbon atoms. during group or P-Sp- (wherein, P is the same meaning as P in a 1, Sp is a 1 has the same meaning as Sp in. However there be the same group or different groups The alkyl groups each independently represent one or more hydrogen atoms replaced by fluorine or chlorine atoms, and one —CH 2 — or adjacent group on the alkyl group. Two or more —CH 2 — are each independently —O—, —S—, —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—. CO—O—, —CO—NH—, —NH—CO—, —CH═CH—COO—, CH═CH—OCO—, —COO—CH═CH—, —OCO—CH═CH—, —CY═CY— or —C≡C— (wherein Y is independently a hydrogen atom or carbon atom number) 1 to 12 represents an alkyl group, a fluorine atom, a chlorine atom or a cyano group.) At least one of R 1 and W 1 represents a carboxyl group. )
Furthermore, the compound (5) having a group selected from at least one hydroxyl group, mercapto group and / or amino group is preferably a compound represented by the following formula (II).

Figure 2013253041
Figure 2013253041

(式中、Gは下記式(ii) (In the formula, G 2 represents the following formula (ii)

Figure 2013253041
Figure 2013253041

(式中、Aは各々独立して1,4−フェニレン基、ナフタレン−2,6−ジイル基、1,4−シクロヘキシレン基、1,4−シクロヘキセニレン基、1,4−ビシクロ[2.2.2]オクチレン基、デカヒドロナフタレン−2,6−ジイル基、1,2,3,4−テトラヒドロナフタレン−2,6−ジイル基、ピリジン−2,6−ジイル基、ピリミジン−2,5−ジイル基、1,3−ジオキサン−2,5−ジイル基又は単結合を表すが、これらの基は無置換又は、各々独立してハロゲン、シアノ基、ニトロ基、ペンタフルオロスルフラニル基又は炭素原子数1から10のアルキル基によって置換されていても良いが、このアルキル基は各々独立して1個以上の水素原子がフッ素原子又は塩素原子により置き換えられても良く、このアルキル基上の1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CY=CY−又は−C≡C−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基、フッ素原子、塩素原子又はシアノ基を表す。)に置き換えられても良く、AはP−Sp−(式中、PはA中のPと同じ意味を表し、SpはAは中のSpと同じ意味を表す。ただし同一の基であっても異なる基であってもよい。)で表される基によって置換されてもいても良く、Z21及びZ22は各々独立して−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CHCH−、−CHCF−、−CFCH−、−CFCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CY=CY−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基、フッ素原子、塩素原子又はシアノ基を表す。)、−C≡C−、−CH=N−、−N=CH−、−N=N−、−CH=N−N=CH−、炭素原子数1から20のアルキレン基又は単結合を表すが、このアルキレン基は各々独立して1個以上の水素原子がフッ素原子又は塩素原子により置き換えられても良く、このアルキレン基上の1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CY=CY−又は−C≡C−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基、フッ素原子、塩素原子又はシアノ基を表す。)に置き換えられても良く、m21は0から8の整数を表す。)を表し、R及びWは各々独立して水素原子、フッ素原子、塩素原子、臭素原子、ヨウ素原子、ペンタフルオロスルフラニル基、シアノ基、ニトロ基、炭素原子数1から20のアルキル基又はP−Sp−(式中、PはA中のPと同じ意味を表し、SpはAは中のSpと同じ意味を表す。ただし同一の基であっても異なる基であってもよい。)を表すが、このアルキル基は各々独立して1個以上の水素原子がフッ素原子又は塩素原子により置き換えられても良く、このアルキル基上の1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CY=CY−又は−C≡C−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基、フッ素原子、塩素原子又はシアノ基を表す。)で置換されても良いが、R及びWのうち少なくとも一方はヒドロキシル基、メルカプト基及び/又はアミノ基から選ばれる基を表す。)
更に、酸ハロゲン化合物(3)は、下記式(III−1)又は式(III−2)で表される化合物であることが好ましい。
(In the formula, each A 2 is independently 1,4-phenylene group, naphthalene-2,6-diyl group, 1,4-cyclohexylene group, 1,4-cyclohexenylene group, 1,4-bicyclo [ 2.2.2] Octylene group, decahydronaphthalene-2,6-diyl group, 1,2,3,4-tetrahydronaphthalene-2,6-diyl group, pyridine-2,6-diyl group, pyrimidine-2 , 5-diyl group, 1,3-dioxane-2,5-diyl group or a single bond, these groups are unsubstituted or each independently halogen, cyano group, nitro group, pentafluorosulfuranyl The alkyl group may be substituted by a group or an alkyl group having 1 to 10 carbon atoms, and each of these alkyl groups may be independently substituted with one or more hydrogen atoms by fluorine atoms or chlorine atoms. The above one —CH 2 — or two or more non-adjacent —CH 2 — are each independently —O—, —S—, —CO—, —COO—, —OCO—, —CO—. S-, -S-CO-, -O-CO-O-, -CO-NH-, -NH-CO-, -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH—, —OCO—CH═CH—, —CY═CY— or —C≡C— (wherein Y is independently a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom) or a cyano group.) may be replaced by, a 2 is in the P-Sp- (wherein, P is the same meaning as P in a 1, Sp is the same meaning as Sp in the a 1 represents. However may be either the same group different group.) it may be had be substituted by a group represented by, Z 21 and Z 2 Each independently -O is -, - S -, - OCH 2 -, - CH 2 O -, - CO -, - COO -, - OCO -, - CO-S -, - S-CO -, - O -CO-O -, - CO- NH -, - NH-CO -, - SCH 2 -, - CH 2 S -, - CF 2 O -, - OCF 2 -, - CF 2 S -, - SCF 2 - , —CH 2 CH 2 —, —CH 2 CF 2 —, —CF 2 CH 2 —, —CF 2 CF 2 —, —CH═CH—COO—, —CH═CH—OCO—, —COO—CH═ CH -, - OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO- CH 2 -, - OCO-CH 2 -, - CH 2 -COO -, - CH 2 -OCO -, - CY = CY- ( wherein, Y each independently represents a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom or a cyano group. ), —C≡C—, —CH═N—, —N═CH—, —N═N—, —CH═N—N═CH—, an alkylene group having 1 to 20 carbon atoms or a single bond. Each of the alkylene groups independently may have one or more hydrogen atoms replaced by fluorine or chlorine atoms, and one —CH 2 — or two or more non-adjacent ones on the alkylene group. —CH 2 — is independently —O—, —S—, —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—CO—O—, — CO-NH-, -NH-CO-, -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH-, -OCO-CH = CH-, -CY = CY- or- C≡C— (wherein Y is independently a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom, Represents a cyano group), and m21 represents an integer of 0 to 8. R 2 and W 2 each independently represent a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a pentafluorosulfuranyl group, a cyano group, a nitro group, or an alkyl having 1 to 20 carbon atoms. during group or P-Sp- (wherein, P is the same meaning as P in a 1, Sp is a 1 has the same meaning as Sp in. However there be the same group or different groups The alkyl groups each independently represent one or more hydrogen atoms replaced by fluorine or chlorine atoms, and one —CH 2 — or adjacent group on the alkyl group. Two or more —CH 2 — are each independently —O—, —S—, —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—. CO—O—, —CO—NH—, —NH—CO—, —CH═CH—COO—, CH═CH—OCO—, —COO—CH═CH—, —OCO—CH═CH—, —CY═CY— or —C≡C— (wherein Y is independently a hydrogen atom or carbon atom number) Represents an alkyl group of 1 to 12, a fluorine atom, a chlorine atom or a cyano group.), But at least one of R 2 and W 2 is selected from a hydroxyl group, a mercapto group and / or an amino group. Represents a group. )
Furthermore, the acid halogen compound (3) is preferably a compound represented by the following formula (III-1) or formula (III-2).

Figure 2013253041
Figure 2013253041

(式中、Uは有機基を表し、Uは水素原子又は有機基を表し、Vはハロゲンを表す。)
混合酸無水物(4)は、下記一般式(IV)で表される化合物であることが好ましい。
(In the formula, U 1 represents an organic group, U 2 represents a hydrogen atom or an organic group, and V represents a halogen.)
The mixed acid anhydride (4) is preferably a compound represented by the following general formula (IV).

Figure 2013253041
Figure 2013253041

(式中、R、G及びWは各々一般式(I)におけるR、G及びWと同じ意味を表すが、一般式(I)においてR及び/又はWがカルボキシル基を表す場合には、対応するR及び/又はWは下記式(IV−1)又は式(IV−2) (Wherein R 3 , G 3 and W 3 each represent the same meaning as R 1 , G 1 and W 1 in formula (I), but in formula (I) R 1 and / or W 1 is carboxyl When a group is represented, the corresponding R 3 and / or W 3 is represented by the following formula (IV-1) or (IV-2)

Figure 2013253041
Figure 2013253041

(式中、U及びUは式(III−1)及び式(III−2)におけるU及びUと同じ意味を表す。)で表される。)
エステル化合物及び/又はアミド化合物(6)は、下記一般式(V−1)から一般式(V−3)で表される化合物であることが好ましい。
(Wherein, U 1 and U 2 is the formula (III-1) and formula (III-2) represent the same meaning as U 1 and U 2 in.) Represented by. )
The ester compound and / or amide compound (6) is preferably a compound represented by the following general formula (V-1) to general formula (V-3).

Figure 2013253041
Figure 2013253041

(式中、Gは一般式(I)におけるGと同じ意味を表し、Gは一般式(II)におけるGと同じ意味を表し、Q及びQは各々独立して−COO−、−OCO−、−CONH−、−NHCO−、−COS−又は−SCO−を表し、R及びWは各々独立して一般式(I)におけるR又はW若しくは一般式(II)におけるR又はWと同じ意味を表す。) Pで表される基はラジカル重合、ラジカル付加重合、カチオン重合及びアニオン重合により硬化する。特に重合方法として紫外線重合を行う場合には、式(P−1)、式(P−2)、式(P−3)、式(P−4)、式(P−5)、式(P−7)、式(P−11)、式(P−13)又は式(P−15)が好ましく、式(P−1)、式(P−2)、式(P−7)、式(P−11)又は式(P−13)がより好ましく、式(P−1)又は式(P−2)が特に好ましい。 (Wherein, G 1 has the same meaning as G 1 in the general formula (I), G 2 has the same meaning as G 2 in the general formula (II), Q 1 and Q 2 are each independently -COO -, -OCO-, -CONH-, -NHCO-, -COS- or -SCO-, wherein R 4 and W 4 are each independently R 1 or W 1 in formula (I) or formula (II) ) Represents the same meaning as R 2 or W 2. ) The group represented by P is cured by radical polymerization, radical addition polymerization, cationic polymerization, and anionic polymerization. In particular, when ultraviolet polymerization is performed as a polymerization method, the formula (P-1), formula (P-2), formula (P-3), formula (P-4), formula (P-5), formula (P -7), formula (P-11), formula (P-13) or formula (P-15) are preferred, and formula (P-1), formula (P-2), formula (P-7), formula (P P-11) or formula (P-13) is more preferred, and formula (P-1) or formula (P-2) is particularly preferred.

Spは1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CY=CY−又は−C≡C−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基、フッ素原子、塩素原子又はシアノ基を表す。)に置き換えられても良い炭素原子数1から20のアルキレン基又は単結合を表すが、本願発明の製造方法により製造される化合物を液晶材料に使用する場合には、液晶性及び他の成分との相溶性の観点から1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−COO−、−OCO−、−O−CO−O−、−CH=CH−COO−、−OCO−CH=CH−、−CY=CY−又は−C≡C−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基を表す。)に置き換えられても良い炭素原子数1から12のアルキレン基又は単結合が好ましく、1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−COO−又は−OCO−に置き換えられても良い炭素原子数1から12のアルキレン基又は単結合がより好ましく、1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−COO−又は−OCO−に置き換えられても良い炭素原子数1から8のアルキレン基又は単結合が特に好ましい。 Sp represents one —CH 2 — or two or more non-adjacent —CH 2 — each independently —O—, —S—, —CO—, —COO—, —OCO—, —CO—. S-, -S-CO-, -O-CO-O-, -CO-NH-, -NH-CO-, -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH—, —OCO—CH═CH—, —CY═CY— or —C≡C— (wherein Y is independently a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom) Or a cyano group), which represents an alkylene group having 1 to 20 carbon atoms or a single bond, which may be replaced with a cyano group, but when the compound produced by the production method of the present invention is used for a liquid crystal material, a liquid crystal sex and -CH view of compatibility one with the other ingredients 2 - or two or more nonadjacent -CH 2 - are each independently -O -, - COO -, - OCO -, - OCO-O -, - CH = CH-COO -, - OCO-CH = CH -, - CY = CY- Or -C≡C- (wherein each Y independently represents a hydrogen atom or an alkyl group having 1 to 12 carbon atoms), an alkylene group having 1 to 12 carbon atoms or a single bond Preferably, one —CH 2 — or two or more non-adjacent —CH 2 — may be each independently replaced by —O—, —COO— or —OCO—. 12 alkylene groups or a single bond are more preferable, and one —CH 2 — or two or more non-adjacent —CH 2 — are each independently replaced with —O—, —COO— or —OCO—. An alkylene group having 1 to 8 carbon atoms or a single bond may be particularly preferable. Arbitrariness.

さらに一般式(I)及び一般式(II)で表される化合物は合成の容易さの観点及び、液晶材料に使用する場合には液晶性の観点から、A及びAは各々独立して無置換又は、各々独立してシアノ基、ニトロ基、各々独立して1個以上の水素原子がフッ素原子又は塩素原子により置き換えられても良く又は/及びこのアルキル基上の1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−に置き換えられても良い炭素原子数1から10のアルキル基若しくは、P−Sp−で表される基によって置換されても良い1,4−フェニレン基、ナフタレン−2,6−ジイル基、1,4−シクロヘキシレン基、1,4−シクロヘキセニレン基、1,4−ビシクロ[2.2.2]オクチレン基、デカヒドロナフタレン−2,6−ジイル基、1,2,3,4−テトラヒドロナフタレン−2,6−ジイル基、ピリジン−2,6−ジイル基、ピリミジン−2,5−ジイル基、1,3−ジオキサン−2,5−ジイル基である場合が好ましく、各々独立して無置換又は、各々独立してシアノ基、ニトロ基、各々独立して1個以上の水素原子がフッ素原子又は塩素原子により置き換えられても良く又は/及びこのアルキル基上の1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−に置き換えられても良い炭素原子数1から10のアルキル基によって置換されても良い1,4−フェニレン基、ナフタレン−2,6−ジイル基、1,4−シクロヘキシレン基である場合がより好ましく、各々独立して無置換又は、各々独立して1個以上の水素原子がフッ素原子により置き換えられても良く又は/及びこのアルキル基上の1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−に置き換えられても良い炭素原子数1から10のアルキル基によって置換されても良い1,4−フェニレン基、ナフタレン−2,6−ジイル基である場合が特に好ましく、
11、Z12、Z21及びZ22は各々独立して−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CHCH−、−CHCF−、−CFCH−、−CFCF−、−CH=CH−COO−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−CY=CY−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基を表す。)、−C≡C−、−CH=N−、−N=CH−、−N=N−、−CH=N−N=CH−、各々独立して1個以上の水素原子がフッ素原子又は塩素原子により置き換えられても良く又は/及び1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−COO−、−OCO−に置き換えられても良い炭素原子数1から20のアルキレン基又は単結合が好ましく、各々独立して−O−、−S−、−OCH−、−CHO−、−COO−、−OCO−、−CHCH−、−CH=CH−COO−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−CY=CY−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基を表す。)、−C≡C−、−CH=N−、−N=CH−、−N=N−、−CH=N−N=CH−、各々独立して1個以上の水素原子がフッ素原子により置き換えられても良い炭素原子数1から20のアルキレン基又は単結合がより好ましく、
m11及びm21は各々独立して1から5の整数である場合が好ましく、1から3の整数である場合がより好ましく、1又は2である場合が特に好ましく、
及びWは各々独立してR及びWのうち両方がカルボキシル基を表すか若しくは、R及びWのうち一方がカルボキシル基を表し、他方が水素原子、フッ素原子、塩素原子、シアノ基又は、各々独立して1個以上の水素原子がフッ素原子又は塩素原子により置き換えられても良く又は/及び1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−COO−、−OCO−に置き換えられても良い炭素原子数1から20のアルキル基又はR及びWはP−Sp−で表される基を表す場合が好ましく、R及びWのうち両方がカルボキシル基を表すか若しくは、R及びWのうち一方がカルボキシル基を表し、他方が水素原子、フッ素原子又は、各々独立して1個以上の水素原子がフッ素原子により置き換えられても良い炭素原子数1から12のアルキル基又はR及びWはP−Sp−で表される基を表す場合がより好ましく、
及びWは各々独立してR及びWのうち両方がヒドロキシル基、メルカプト基及び/又はアミノ基から選ばれる基を表すか若しくは、R及びWのうち一方がヒドロキシル基、メルカプト基及び/又はアミノ基から選ばれる基を表し、他方が水素原子、フッ素原子、塩素原子、シアノ基又は、各々独立して1個以上の水素原子がフッ素原子又は塩素原子により置き換えられても良く又は/及び1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−COO−、−OCO−に置き換えられても良い炭素原子数1から20のアルキル基又はR及びWはP−Sp−で表される基を表す場合が好ましく、R及びWのうち両方がヒドロキシル基を表すか若しくは、R及びWのうち一方がヒドロキシル基を表し、他方が水素原子、フッ素原子又は、各々独立して1個以上の水素原子がフッ素原子により置き換えられても良い炭素原子数1から12のアルキル基又はR及びWはP−Sp−で表される基を表す場合がより好ましく、
及びWの両方がカルボキシル基を表す場合には、R及びWの一方のみがヒドロキシル基、メルカプト基及び/又はアミノ基から選ばれる基を表す場合が好ましく、R及びWの一方のみがヒドロキシル基を表す場合がより好ましく、
及びWの両方がヒドロキシル基、メルカプト基及び/又はアミノ基から選ばれる基を表す場合には、R及びWの一方のみがカルボキシル基を表す場合が好ましい。
Furthermore, the compounds represented by the general formula (I) and the general formula (II) are each independently A 1 and A 2 from the viewpoint of ease of synthesis and from the viewpoint of liquid crystallinity when used in a liquid crystal material. Unsubstituted or each independently a cyano group, a nitro group, each independently one or more hydrogen atoms may be replaced by a fluorine atom or a chlorine atom or / and one —CH 2 on this alkyl group - or nonadjacent two or more -CH 2 - are each independently -O -, - S -, - CO -, - COO -, - OCO- from a good carbon atoms 1 be replaced by 10 1,4-phenylene group, naphthalene-2,6-diyl group, 1,4-cyclohexylene group, 1,4-cyclohexeni group which may be substituted by an alkyl group of the above or a group represented by P-Sp- Ren group, 1,4-bicyclo [2.2. ] Octylene group, decahydronaphthalene-2,6-diyl group, 1,2,3,4-tetrahydronaphthalene-2,6-diyl group, pyridine-2,6-diyl group, pyrimidine-2,5-diyl group 1,3-dioxane-2,5-diyl group, preferably each independently unsubstituted or each independently cyano group, nitro group, each independently one or more hydrogen atoms are fluorine atoms or may be replaced by chlorine atoms and / or one -CH on the alkyl group 2 - or nonadjacent two or more -CH 2 - are each independently -O -, - S-, 1,4-phenylene group, naphthalene-2,6-diyl group, which may be substituted by an alkyl group having 1 to 10 carbon atoms which may be replaced by -CO-, -COO-, -OCO-, 4-cyclohexyle More preferably is a group, each independently unsubstituted or, respectively even independently one or more hydrogen atoms are replaced by fluorine atoms may or / and one -CH 2 on the alkyl group - Alternatively, two or more non-adjacent —CH 2 — may be independently replaced with —O—, —S—, —CO—, —COO—, —OCO—. Particularly preferred is a 1,4-phenylene group or a naphthalene-2,6-diyl group which may be substituted by an alkyl group,
Z 11 , Z 12 , Z 21 and Z 22 are each independently —O—, —S—, —OCH 2 —, —CH 2 O—, —CO—, —COO—, —OCO—, —CO—. S -, - S-CO - , - O-CO-O -, - CO-NH -, - NH-CO -, - SCH 2 -, - CH 2 S -, - CF 2 O -, - OCF 2 - , —CF 2 S—, —SCF 2 —, —CH 2 CH 2 —, —CH 2 CF 2 —, —CF 2 CH 2 —, —CF 2 CF 2 —, —CH═CH—COO—, —OCO -CH = CH -, - COO- CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - CY = CY- ( wherein , Y each independently represents a hydrogen atom or an alkyl group having 1 to 12 carbon atoms.), —C≡C—, —CH═N—, — = CH -, - N = N -, - CH = N-N = CH-, be each independently one or more hydrogen atoms are replaced by fluorine atom or chlorine atom may and / or one -CH 2 - or nonadjacent two or more -CH 2 - are each independently -O -, - S -, - COO -, - OCO- the replaced be an alkylene group having 1 to 20 carbon atoms Or a single bond is preferable, and each independently represents —O—, —S—, —OCH 2 —, —CH 2 O—, —COO—, —OCO—, —CH 2 CH 2 —, —CH═CH—COO. -, - OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - CY = CY -(Wherein Y is independently a hydrogen atom, an alkyl having 1 to 12 carbon atoms, -C≡C-, -CH = N-, -N = CH-, -N = N-, -CH = N-N = CH-, each independently one or more hydrogen atoms Is more preferably an alkylene group having 1 to 20 carbon atoms which may be replaced by a fluorine atom or a single bond,
m11 and m21 are each independently preferably an integer of 1 to 5, more preferably an integer of 1 to 3, particularly preferably 1 or 2.
R 1 and W 1 are each independently R 1 and W 1 both represent a carboxyl group, or one of R 1 and W 1 represents a carboxyl group, the other is a hydrogen atom, a fluorine atom, a chlorine atom , A cyano group, or each independently one or more hydrogen atoms may be replaced by a fluorine atom or a chlorine atom or / and one —CH 2 — or two or more —CH 2 — not adjacent to each other. Each independently can be replaced by -O-, -S-, -COO-, -OCO-, or an alkyl group having 1 to 20 carbon atoms or R 1 and W 1 are represented by P-Sp- In the case of a group, preferably both of R 1 and W 1 represent a carboxyl group, or one of R 1 and W 1 represents a carboxyl group, and the other represents a hydrogen atom, a fluorine atom, or each independently One or more hydrogen atoms It is more preferable that R 1 and W 1 represent a group represented by P-Sp-, or an alkyl group having 1 to 12 carbon atoms which may be replaced by a fluorine atom,
R 2 and W 2 each independently both hydroxyl groups of R 2 and W 2, or represent a group selected from mercapto and / or amino group, one hydroxyl group of R 2 and W 2, Represents a group selected from a mercapto group and / or an amino group, the other being a hydrogen atom, a fluorine atom, a chlorine atom, a cyano group, or each independently one or more hydrogen atoms being replaced by a fluorine atom or a chlorine atom And / or one —CH 2 — or two or more non-adjacent —CH 2 — may be independently replaced with —O—, —S—, —COO—, —OCO—. Preferably, the alkyl group having 1 to 20 carbon atoms or R 2 and W 2 represents a group represented by P—Sp—, and both of R 2 and W 2 represent a hydroxyl group, or R 2 and W 2 One represents a hydroxyl group, and the other represents a hydrogen atom, a fluorine atom, or an alkyl group having 1 to 12 carbon atoms in which one or more hydrogen atoms may be each independently replaced by a fluorine atom, or R 2 and W 2 is more preferably a group represented by P-Sp-,
If both R 1 and W 1 represents a carboxyl group, if it represents a group only one of R 2 and W 2 is selected from hydroxyl group, a mercapto group and / or amino group are preferred, R 2 and W 2 More preferably, only one of these represents a hydroxyl group,
When both R 2 and W 2 represent a group selected from a hydroxyl group, a mercapto group and / or an amino group, it is preferable that only one of R 1 and W 1 represents a carboxyl group.

以下にさらに具体的な実施形態を記載するが、単純化のため少なくとも一つのカルボキシル基を有する化合物(1)をカルボン酸、少なくとも一つのヒドロキシル基、メルカプト基及び/又はアミノ基から選ばれる基を有する化合物(4)を求核剤と表記する。   More specific embodiments will be described below. For simplicity, the compound (1) having at least one carboxyl group is converted to a group selected from carboxylic acid, at least one hydroxyl group, mercapto group and / or amino group. The compound (4) having is represented as a nucleophile.

酸ハロゲン化合物(3)は、スルホン酸ハロゲン化合物又はカルボン酸ハロゲン化合物であることが好ましいが、塩基存在下カルボン酸と反応することにより、脱離性の置換基を有するカルボン酸誘導体を生じさせ、さらに、当該カルボン酸誘導体が求核剤と反応することにより脱離性の置換基が効率良く脱離するものが好ましい。入手容易な酸ハロゲン化合物として、例えば、メタンスルホン酸クロリド、トルエンスルホン酸クロリド、アセチルクロリド等が挙げられる。   The acid halogen compound (3) is preferably a sulfonic acid halogen compound or a carboxylic acid halogen compound, but reacts with a carboxylic acid in the presence of a base to give a carboxylic acid derivative having a detachable substituent, Furthermore, it is preferable that the carboxylic acid derivative reacts with a nucleophile so that the detachable substituent is efficiently eliminated. Examples of readily available acid halogen compounds include methanesulfonic acid chloride, toluenesulfonic acid chloride, acetyl chloride, and the like.

使用する酸ハロゲン化合物(3)の量は特に制限は無いが、カルボン酸に対して1当量未満の場合には反応後に未反応のカルボン酸が残留する。そのため、反応後の精製によって未反応のカルボン酸を除去しなければならない。通常、カラムクロマトグラフィー、再結晶、再沈殿、蒸留、昇華等の方法によってカルボン酸を除去することが可能である。一方、酸ハロゲン化合物の量がカルボン酸に対して1当量より多い場合には反応後に酸ハロゲン化合物が残留する。その場合にも同様の方法によって精製が可能である。好ましくはカルボン酸に対して0.1〜10当量であり、精製の容易さの観点からより好ましくは0.5〜2当量であり、さらに好ましくは0.8〜1.5当量である。   The amount of the acid halogen compound (3) to be used is not particularly limited, but if it is less than 1 equivalent to the carboxylic acid, unreacted carboxylic acid remains after the reaction. Therefore, unreacted carboxylic acid must be removed by purification after the reaction. Usually, the carboxylic acid can be removed by a method such as column chromatography, recrystallization, reprecipitation, distillation, sublimation or the like. On the other hand, when the amount of the acid halogen compound is more than 1 equivalent with respect to the carboxylic acid, the acid halogen compound remains after the reaction. In that case, purification can be performed by the same method. Preferably it is 0.1-10 equivalent with respect to carboxylic acid, More preferably, it is 0.5-2 equivalent from a viewpoint of the ease of refinement | purification, More preferably, it is 0.8-1.5 equivalent.

塩基(2)は、アミン、アミド、カルバメート、イミド、スルホンアミド、グアニジン、ヒドラゾン、ヒドラジド、ヒドラジン、複素環アミン、それらの塩、金属アルコキシド又は金属水酸化物であることが好ましいが、収率の観点から第三級アミン又は芳香族アミン並びに当該アミン塩がより好ましい。入手容易な塩基として例えば、トリメチルアミン、N,N−ジメチルエチルアミン、N,N−ジエチルメチルアミン、トリエチルアミン、N,N−ジメチルプロピルアミン、N,N−ジメチルブチルアミン、N,N−ジメチルペンチルアミン、N,N−ジエチルプロピルアミン、N,N−ジプロピルエチルアミン、N,N−ジプロピルメチルアミン、N,N−ジエチルペンチルアミン、N−エチル−N−メチルペンチルアミン、トリブチルアミン、N,N−ジブチルメチルアミン、N,N−ジブチルエチルアミン、N,N−ジブチルプロピルアミン、N−エチル−N−メチルプロピルアミン、N,N−ジプロピルメチルアミン、N,N−ジプロピルエチルアミン、トリプロピルアミン、トリイソプロピルアミン、N−メチルジイソプロピルアミン、N−エチルジイソプロピルアミン、N−プロピルジイソプロピルアミン、N−ブチルジイソプロピルアミン、ピリジン、N−メチルピリジン、2−クロロピリジン、2−ブロモピリジン、ピペリジン、ピリミジン、キノリン、アクリジン、N,N−ジメチル−4−アミノピリジン、ピコリン、ビピリジン、2,6−ルチジン、クロロクロム酸ピリジニウム、ピリジニウムパラトルエンスルホナート等が挙げられる。塩基は一種類のみを用いても、二種類以上を用いても良い。また、カルボン酸と塩基とを予め混合すること無く、酸ハロゲン化合物に対し加え反応させる工程と、求核剤を反応させる工程とからなる製造方法を実施する場合には、塩基を第一工程(少なくとも一つのカルボキシル基を有する化合物(1)、塩基(2)及び酸ハロゲン化合物(3)から混合酸無水物(4)を得る工程)においてのみ使用しても良く若しくは、第一工程及び第二工程(混合酸無水物(4)及び、少なくとも一つのヒドロキシル基、メルカプト基及び/又はアミノ基から選ばれる基を有する化合物(5)からエステル化合物及び/又はアミド化合物(6)を得る工程)の両方において使用しても良い。   The base (2) is preferably an amine, amide, carbamate, imide, sulfonamide, guanidine, hydrazone, hydrazide, hydrazine, heterocyclic amine, a salt thereof, a metal alkoxide or a metal hydroxide. From the viewpoint, tertiary amines or aromatic amines and the amine salts are more preferable. Examples of easily available bases include trimethylamine, N, N-dimethylethylamine, N, N-diethylmethylamine, triethylamine, N, N-dimethylpropylamine, N, N-dimethylbutylamine, N, N-dimethylpentylamine, N , N-diethylpropylamine, N, N-dipropylethylamine, N, N-dipropylmethylamine, N, N-diethylpentylamine, N-ethyl-N-methylpentylamine, tributylamine, N, N-dibutyl Methylamine, N, N-dibutylethylamine, N, N-dibutylpropylamine, N-ethyl-N-methylpropylamine, N, N-dipropylmethylamine, N, N-dipropylethylamine, tripropylamine, tripropylamine Isopropylamine, N-methyldiisopropyla , N-ethyldiisopropylamine, N-propyldiisopropylamine, N-butyldiisopropylamine, pyridine, N-methylpyridine, 2-chloropyridine, 2-bromopyridine, piperidine, pyrimidine, quinoline, acridine, N, N-dimethyl Examples include -4-aminopyridine, picoline, bipyridine, 2,6-lutidine, pyridinium chlorochromate, pyridinium paratoluenesulfonate, and the like. Only one type of base may be used, or two or more types may be used. In the case of carrying out a production method comprising a step of reacting with an acid halogen compound without adding a carboxylic acid and a base in advance and a step of reacting a nucleophile, the base is added to the first step ( May be used only in the step of obtaining the mixed acid anhydride (4) from the compound (1) having at least one carboxyl group, the base (2) and the acid halogen compound (3), or the first step and the second step. Step (Step of obtaining ester compound and / or amide compound (6) from compound acid anhydride (4) and compound (5) having a group selected from at least one hydroxyl group, mercapto group and / or amino group) It may be used in both.

第一工程及び第二工程ともに反応温度は通常−50℃から150℃であるが、溶媒を用いる場合には−50℃から溶媒の還流温度である。収率の観点から−50℃から60℃が好ましく、作業の効率性の観点から−10℃から40℃がより好ましい。   In both the first step and the second step, the reaction temperature is usually from −50 ° C. to 150 ° C., but when a solvent is used, the reaction temperature is from −50 ° C. to the reflux temperature of the solvent. From the viewpoint of yield, −50 ° C. to 60 ° C. is preferable, and from the viewpoint of work efficiency, −10 ° C. to 40 ° C. is more preferable.

酸ハロゲン化合物(3)はそのまま用いても、溶媒に溶解させ溶液として用いても、溶媒に懸濁させ懸濁液として用いても良いが、収率及び反応制御の観点から溶液又は懸濁液として用いることが好ましい。   The acid halogen compound (3) may be used as it is, dissolved in a solvent and used as a solution, suspended in a solvent and used as a suspension, but from the viewpoint of yield and reaction control, the solution or suspension It is preferable to use as.

カルボン酸、塩基(2)及び求核剤は、各々そのまま用いても、溶媒に溶解させ溶液として用いても、溶媒に懸濁させ懸濁液として用いても良いが、収率及び反応制御の観点から溶液又は懸濁液として用いることが好ましく、溶液として用いることがより好ましい。   Carboxylic acid, base (2) and nucleophile may be used as they are, dissolved in a solvent and used as a solution, suspended in a solvent and used as a suspension. From the viewpoint, it is preferably used as a solution or suspension, and more preferably used as a solution.

カルボン酸と、塩基とを予め混合すること無く、酸ハロゲン化合物に対し加え反応させる第一工程は下記化学式
(カルボン酸)+k(酸ハロゲン化合物)+k(塩基)→(混合酸無水物)+k(塩)
(式中、kはカルボン酸1当量に対し必要となる、酸ハロゲン化合物及び塩基の当量数を表す。)で表すことができる。収率の観点から、カルボン酸と塩基とを混合せずに同時に加えることが好ましく、カルボン酸と塩基の滴下速度が、
(カルボン酸の滴下速度):(塩基の滴下速度)=k:1
であることがより好ましい。
The first step of adding and reacting the carboxylic acid and the base to the acid halogen compound without mixing them in advance is the following chemical formula (carboxylic acid) + k (acid halogen compound) + k (base) → (mixed acid anhydride) + k ( salt)
(Wherein, k represents the number of equivalents of acid halogen compound and base required for 1 equivalent of carboxylic acid). From the viewpoint of yield, it is preferable to add the carboxylic acid and the base simultaneously without mixing, and the dropping rate of the carboxylic acid and the base is
(Drop rate of carboxylic acid) :( Drip rate of base) = k: 1
It is more preferable that

第一工程により得られた混合酸無水物(4)は、単離しても良く、単離せずにそのまま第二工程へと用いても良い。単離する場合は、通常の方法により後処理及び精製を行うことができる。収率及び作業効率の観点から、単離せずにそのまま第二工程へと用いるワンポット反応が好ましい。
求核剤を反応させる第二工程は下記化学式
(混合酸無水物)+l(求核剤)+l(塩基)→(目的物)+l(塩)
(式中、lは混合酸無水物1当量に対し必要となる、求核剤及び塩基の当量数を表す。)で表すことができる。第一工程及び第二工程で必要となる塩基の当量はカルボン酸に対し(k+l)倍である。ワンポットで反応を行う場合には、第一工程において(k+l)当量の塩基を加えても良く、第一工程においてk当量の塩基を加え、第二工程においてl当量の塩基を加えても良い。また、塩基の当量は理論上必要となる量であっても良く、小過剰又は大過剰であっても良い。収率及び経済性の観点から、塩基の量は理論上必要となる量に対し小過剰であることが好ましい。
The mixed acid anhydride (4) obtained in the first step may be isolated or may be used as it is for the second step without isolation. In the case of isolation, post-treatment and purification can be performed by a usual method. From the viewpoint of yield and work efficiency, a one-pot reaction that is directly used for the second step without isolation is preferred.
The second step of reacting the nucleophilic agent is the following chemical formula (mixed acid anhydride) + l (nucleophilic agent) + l (base) → (target product) + l (salt)
(Wherein 1 represents the number of equivalents of nucleophile and base required for 1 equivalent of mixed acid anhydride). The equivalent of the base required in the first step and the second step is (k + 1) times the carboxylic acid. When the reaction is carried out in one pot, (k + 1) equivalent base may be added in the first step, k equivalent base may be added in the first step, and 1 equivalent base may be added in the second step. In addition, the equivalent amount of the base may be a theoretically required amount, or a small excess or a large excess. From the viewpoint of yield and economy, the amount of base is preferably a small excess relative to the theoretically required amount.

第一工程及び第二工程ともに反応時間は化合物にもよるが通常数分間〜数日間であり、好ましくは数十分から数時間である。   In both the first step and the second step, the reaction time is usually from several minutes to several days, although it depends on the compound, and preferably from several tens of minutes to several hours.

第一工程及び第二工程ともに反応溶媒としては、反応過程において目的の化合物を与えるものであれば特に制限は無いが、好ましい反応溶媒として例えば、クロロホルム、四塩化炭素、ジクロロメタン、1,2−ジクロロエタン、1,2−ジクロロエチレン、1,1,2,2−テトラクロロエタン、トリクロロエチレン、1−クロロブタン、二硫化炭素、アセトン、アセトニトリル、ベンゾニトリル、N,N−ジメチルホルムアミド、N,N−ジメチルアセトアミド、ジメチルスルホキシド、ジエチルエーテル、エチレングリコールモノエチルエーテル、エチレングリコールモノエチルエーテルアセテート、エチレングリコールモノブチルエーテル、エチレングリコールモノメチルエーテル、ジエチレングリコールジエチルエーテル、o−ジクロロベンゼン、キシレン、o−キシレン、p−キシレン、m−キシレン、クロロベンゼン、酢酸イソブチル、酢酸イソプロピル、酢酸イソアミル、酢酸エチル、酢酸ブチル、酢酸プロピル、酢酸ペンチル、酢酸メチル、酢酸2−メトキシエチル、ヘキサメチルリン酸トリアミド、トリス(ジメチルアミノ)ホスフィン、シクロヘキサノン、1,4−ジオキサン、スチレン、テトラクロロエチレン、テトラヒドロフラン、ピリジン、1−メチル−2−ピロリジノン、1,1,1−トリクロロエタン、トルエン、ヘキサン、ペンタン、シクロヘキサン、シクロペンタン、ヘプタン、ベンゼン、メチルイソブチルケトン、tert−ブチルメチルエーテル、メチルエチルケトン、メチルシクロヘキサノン、メチルブチルケトン、ジエチルケトン、ガソリン、コールタールナフサ、石油エーテル、石油ナフサ、石油ベンジン、テレビン油、ミネラルスピリットが挙げられる。化合物の溶解性の観点から、クロロホルム、ジクロロメタン、1,2−ジクロロエタン、アセトン、アセトニトリル、N,N−ジメチルホルムアミド、N,N−ジメチルアセトアミド、ジメチルスルホキシド、ジエチルエーテル、エチレングリコールモノエチルエーテル、酢酸エチル、酢酸ブチル、1,4−ジオキサン、テトラヒドロフラン、1−メチル−2−ピロリジノン、トルエン、tert−ブチルメチルエーテル、メチルエチルケトンが好ましい。   The reaction solvent in both the first step and the second step is not particularly limited as long as it gives the target compound in the reaction process. Preferred reaction solvents include, for example, chloroform, carbon tetrachloride, dichloromethane, 1,2-dichloroethane. 1,2-dichloroethylene, 1,1,2,2-tetrachloroethane, trichloroethylene, 1-chlorobutane, carbon disulfide, acetone, acetonitrile, benzonitrile, N, N-dimethylformamide, N, N-dimethylacetamide, dimethyl Sulfoxide, diethyl ether, ethylene glycol monoethyl ether, ethylene glycol monoethyl ether acetate, ethylene glycol monobutyl ether, ethylene glycol monomethyl ether, diethylene glycol diethyl ether, o-di Lolobenzene, xylene, o-xylene, p-xylene, m-xylene, chlorobenzene, isobutyl acetate, isopropyl acetate, isoamyl acetate, ethyl acetate, butyl acetate, propyl acetate, pentyl acetate, methyl acetate, 2-methoxyethyl acetate, hexamethyl Phosphoric triamide, tris (dimethylamino) phosphine, cyclohexanone, 1,4-dioxane, styrene, tetrachloroethylene, tetrahydrofuran, pyridine, 1-methyl-2-pyrrolidinone, 1,1,1-trichloroethane, toluene, hexane, pentane, cyclohexane , Cyclopentane, heptane, benzene, methyl isobutyl ketone, tert-butyl methyl ether, methyl ethyl ketone, methyl cyclohexanone, methyl butyl ketone, diethyl ketone, Sorin, coal tar naphtha, petroleum ether, petroleum naphtha, petroleum benzine, turpentine oil, and mineral spirits. From the viewpoint of compound solubility, chloroform, dichloromethane, 1,2-dichloroethane, acetone, acetonitrile, N, N-dimethylformamide, N, N-dimethylacetamide, dimethyl sulfoxide, diethyl ether, ethylene glycol monoethyl ether, ethyl acetate , Butyl acetate, 1,4-dioxane, tetrahydrofuran, 1-methyl-2-pyrrolidinone, toluene, tert-butyl methyl ether, and methyl ethyl ketone are preferred.

以下、実施例を挙げて本発明を更に記述するが、本発明はこれらの実施例に限定されるものではない。また、以下の実施例及び比較例の組成物における「%」は『質量%』を意味する。   EXAMPLES Hereinafter, although an Example is given and this invention is further described, this invention is not limited to these Examples. Further, “%” in the compositions of the following Examples and Comparative Examples means “% by mass”.

化合物の純度はGC又はHPLCによって分析した。分析条件は以下の通りである。
(GC分析条件)
カラム:J&W DB−1,30m×0.25mm×0.25μm
温度プログラム:100℃(1分間)−(10℃/分間)−300℃(12分間)
注入口温度:300℃
検出器温度:300℃
(HPLC分析条件)
カラム:Inertsil ODS−3,5μm,4.6mmφ×250mm
溶出溶媒:アセトニトリル/水(90:10)
流速:0.5mL/min
検出器:UV,210nm
カラムオーブン:40℃
(実施例1)式(I−1)で表される化合物(特許文献3記載の化合物)の製造
Compound purity was analyzed by GC or HPLC. The analysis conditions are as follows.
(GC analysis conditions)
Column: J & W DB-1, 30 m × 0.25 mm × 0.25 μm
Temperature program: 100 ° C (1 minute)-(10 ° C / minute)-300 ° C (12 minutes)
Inlet temperature: 300 ° C
Detector temperature: 300 ° C
(HPLC analysis conditions)
Column: Inertsil ODS-3, 5 μm, 4.6 mmφ × 250 mm
Elution solvent: acetonitrile / water (90:10)
Flow rate: 0.5 mL / min
Detector: UV, 210nm
Column oven: 40 ° C
(Example 1) Production of compound represented by formula (I-1) (compound described in Patent Document 3)

Figure 2013253041
Figure 2013253041

撹拌装置、温度計及び2つの滴下ロートを備えた反応容器にクロロギ酸エチル5.00g(46ミリモル)及びテトラヒドロフラン25mLを加えた。氷冷しながら酢酸2.77g(46ミリモル)のテトラヒドロフラン溶液10mL及びトリブチルアミン10.2g(55ミリモル)のテトラヒドロフラン溶液20mLを各々別の滴下ロートから(酢酸溶液):(トリブチルアミン溶液)=1:2の滴下速度で同時に滴下した。氷冷下30分間撹拌した後、ジクロロメタンを用いて分液処理し溶媒を留去することにより式(I−1)で表される化合物7.16gを得た。収率98%、純度99.97%であった。得られた化合物のH NMR、13C NMR及びマススペクトルを測定した結果、特許文献3記載の方法によって得られた化合物の測定データと一致した。
(比較例1)特許文献3記載の製法
撹拌装置、温度計及び滴下ロートを備えた反応容器に、クロロギ酸エチル5.00g(46ミリモル)及びテトラヒドロフラン25mLを加えた。−10℃に冷却しながら酢酸2.77g(46ミリモル)のトリブチルアミン10.2g(55ミリモル)及びテトラヒドロフラン 20mLからなる溶液を0℃以下で滴下した。氷冷下30分間撹拌した後、ジクロロメタンを用いて分液処理し溶媒を留去することにより式(I−1)で表される化合物を得た。収率92%、純度99.89%であった。
(実施例2)式(I−2)で表される化合物(特許文献3記載の化合物)の製造
To a reaction vessel equipped with a stirrer, a thermometer and two dropping funnels, 5.00 g (46 mmol) of ethyl chloroformate and 25 mL of tetrahydrofuran were added. While cooling with ice, 10 mL of a tetrahydrofuran solution of 2.77 g (46 mmol) of acetic acid and 20 mL of a tetrahydrofuran solution of 10.2 g (55 mmol) of tributylamine were separately added from a separate dropping funnel (acetic acid solution) :( tributylamine solution) = 1: It was dripped simultaneously with the dripping speed of 2. After stirring for 30 minutes under ice cooling, liquid separation treatment was performed using dichloromethane, and the solvent was distilled off to obtain 7.16 g of a compound represented by the formula (I-1). The yield was 98% and the purity was 99.97%. As a result of measuring 1 H NMR, 13 C NMR and mass spectrum of the obtained compound, it was consistent with the measurement data of the compound obtained by the method described in Patent Document 3.
(Comparative Example 1) 5.00 g (46 mmol) of ethyl chloroformate and 25 mL of tetrahydrofuran were added to a reaction vessel equipped with a production stirrer described in Patent Document 3, a thermometer, and a dropping funnel. While cooling to −10 ° C., a solution consisting of 2.77 g (46 mmol) of acetic acid 10.2 g (55 mmol) of tributylamine and 20 mL of tetrahydrofuran was added dropwise at 0 ° C. or lower. After stirring for 30 minutes under ice cooling, liquid separation treatment was performed using dichloromethane, and the solvent was distilled off to obtain a compound represented by the formula (I-1). The yield was 92% and the purity was 99.89%.
(Example 2) Production of compound represented by formula (I-2) (compound described in Patent Document 3)

Figure 2013253041
Figure 2013253041

撹拌装置、温度計及び2つの滴下装置を備えた反応容器にメタンスルホニルクロリド15.0g(0.13モル)及びテトラヒドロフラン30mLを加えた。氷冷しながら式(I−2−1)で表される化合物34.6g(0.13モル)のテトラヒドロフラン溶液200mL及びトリブチルアミン28.9g(0.16モル)のテトラヒドロフラン溶液100mLを各々別の滴下装置から(式(I−2−1)で表される化合物の溶液):(トリブチルアミン溶液)=2:1の滴下速度で同時に滴下した。氷冷しながら1時間撹拌した後、ジクロロメタンを用いて分液処理し溶媒を留去することにより式(I−2)で表される化合物43.9gを得た。収率98%、純度95.53%であった。得られた化合物のH NMR、13C NMR及びマススペクトルを測定した結果、特許文献3記載の方法によって得られた化合物の測定データと一致した。
(比較例2)
実施例2と同様の反応スケールで比較例1と同様の方法により式(I−2)で表される化合物を製造した。収率94%、純度95.50%であった。
(実施例3)式(I−3)で表される化合物の製造
15.0 g (0.13 mol) of methanesulfonyl chloride and 30 mL of tetrahydrofuran were added to a reaction vessel equipped with a stirrer, a thermometer and two dropping devices. While cooling with ice, 200 mL of a tetrahydrofuran solution of 34.6 g (0.13 mol) of the compound represented by formula (I-2-1) and 100 mL of a tetrahydrofuran solution of 28.9 g (0.16 mol) of tributylamine were separately added. From the dropping device, (the solution of the compound represented by the formula (I-2-1)) :( tributylamine solution) = 2: 1 at the same time. After stirring for 1 hour while cooling with ice, liquid separation treatment was performed using dichloromethane, and the solvent was distilled off to obtain 43.9 g of a compound represented by the formula (I-2). The yield was 98% and the purity was 95.53%. As a result of measuring 1 H NMR, 13 C NMR and mass spectrum of the obtained compound, it was consistent with the measurement data of the compound obtained by the method described in Patent Document 3.
(Comparative Example 2)
A compound represented by the formula (I-2) was produced by the same method as in Comparative Example 1 with the same reaction scale as in Example 2. The yield was 94% and the purity was 95.50%.
Example 3 Production of Compound Represented by Formula (I-3)

Figure 2013253041
Figure 2013253041

撹拌装置、温度計及び2つの滴下装置を備えた反応装置にメタンスルホニルクロリド5.00g(43.6ミリモル)及びテトラヒドロフラン10mLを加えた。氷冷しながら式(I−3−1)で表される化合物12.9g(44.1ミリモル)のテトラヒドロフラン溶液60mL及びトリエチルアミン5.25g(51.9ミリモル)のテトラヒドロフラン溶液30mLを各々別の滴下装置から(式(I−3−1)で表される化合物の溶液):(トリエチルアミン溶液)=2:1の滴下速度で同時に滴下した。氷冷しながら1時間撹拌した後、4−ジメチルアミノピリジン2.64g(21.6ミリモル)及び2−(4−ヒドロキシフェニル)エタノール2.69g(19.4ミリモル)を加えた。氷冷しながらトリエチルアミン5.25g(51.9ミリモル)を滴下した。7時間撹拌した後、溶媒を留去し、ジクロロメタン及び5%塩酸を加え分液処理した。有機層を食塩水で洗浄し中和した後、カラムクロマトグラフィー(シリカゲル)及び再沈殿(ジクロロメタン/メタノール)により精製を行い、式(I−3)で表される化合物12.2gを得た。収率82%、純度99.63%であった。
H NMR(CDCl)δ 1.45−1.54(m,8H),1.72(m,4H),1.83(m,4H),3.08(t,2H),4.03(quin,4H),4.18(quin,4H),4.51(t,2H),5.83(d,2H),6.13(dd,2H),6.38(d,2H),6.89(d,2H),6.96(d,2H),7.15(d,2H),7.32(d,2H),7.96(d,2H),8.13(d,2H)ppm.
LRMS(EI) m/z 686(100).
(比較例3〜6)
実施例3と同様の反応スケールで第一工程における試薬の加え方のみを下記の方法に変更し式(I−3)で表される化合物を製造した。
比較例3の試薬の加え方:メタンスルホニルクロリドと式(I−3−1)で表される化合物を混合したテトラヒドロフラン溶液に対し、トリエチルアミンのテトラヒドロフラン溶液を滴下した。
比較例4の試薬の加え方:トリエチルアミンのテトラヒドロフラン溶液に対し、メタンスルホニルクロリドと式(I−3−1)で表される化合物を混合したテトラヒドロフラン溶液を滴下した。
比較例5の試薬の加え方:メタンスルホニルクロリドのテトラヒドロフラン溶液に対し、トリエチルアミンのテトラヒドロフラン溶液を滴下し、その後、式(I−3−1)で表される化合物のテトラヒドロフラン溶液を滴下した。
比較例6の試薬の加え方:メタンスルホニルクロリドのテトラヒドロフラン溶液に対し、トリエチルアミンと式(I−3−1)で表される化合物を混合したテトラヒドロフラン溶液を滴下した。
結果を表1に示す。
To a reaction apparatus equipped with a stirrer, a thermometer and two dropping devices, 5.00 g (43.6 mmol) of methanesulfonyl chloride and 10 mL of tetrahydrofuran were added. While cooling with ice, 60 mL of a tetrahydrofuran solution of 12.9 g (44.1 mmol) of the compound represented by formula (I-3-1) and 30 mL of a tetrahydrofuran solution of 5.25 g (51.9 mmol) of triethylamine were separately added dropwise. From the apparatus, (solution of the compound represented by the formula (I-3-1)) :( triethylamine solution) = 2: 1 at the same time. After stirring for 1 hour while cooling with ice, 2.64 g (21.6 mmol) of 4-dimethylaminopyridine and 2.69 g (19.4 mmol) of 2- (4-hydroxyphenyl) ethanol were added. While cooling with ice, 5.25 g (51.9 mmol) of triethylamine was added dropwise. After stirring for 7 hours, the solvent was distilled off, and dichloromethane and 5% hydrochloric acid were added for liquid separation. The organic layer was washed with brine and neutralized, and then purified by column chromatography (silica gel) and reprecipitation (dichloromethane / methanol) to obtain 12.2 g of a compound represented by the formula (I-3). The yield was 82% and the purity was 99.63%.
1 H NMR (CDCl 3 ) δ 1.45-1.54 (m, 8H), 1.72 (m, 4H), 1.83 (m, 4H), 3.08 (t, 2H), 4. 03 (quin, 4H), 4.18 (quin, 4H), 4.51 (t, 2H), 5.83 (d, 2H), 6.13 (dd, 2H), 6.38 (d, 2H) ), 6.89 (d, 2H), 6.96 (d, 2H), 7.15 (d, 2H), 7.32 (d, 2H), 7.96 (d, 2H), 8.13 (D, 2H) ppm.
LRMS (EI) m / z 686 (100).
(Comparative Examples 3-6)
A compound represented by the formula (I-3) was produced by changing the method of addition of the reagent in the first step only in the same reaction scale as in Example 3 to the following method.
How to add the reagent of Comparative Example 3: A tetrahydrofuran solution of triethylamine was added dropwise to a tetrahydrofuran solution in which methanesulfonyl chloride and a compound represented by the formula (I-3-1) were mixed.
How to add the reagent of Comparative Example 4: To a tetrahydrofuran solution of triethylamine, a tetrahydrofuran solution in which methanesulfonyl chloride and a compound represented by the formula (I-3-1) were mixed was added dropwise.
How to add the reagent of Comparative Example 5: A tetrahydrofuran solution of triethylamine was dropped into a tetrahydrofuran solution of methanesulfonyl chloride, and then a tetrahydrofuran solution of a compound represented by the formula (I-3-1) was dropped.
How to add the reagent of Comparative Example 6: To a tetrahydrofuran solution of methanesulfonyl chloride, a tetrahydrofuran solution in which triethylamine and a compound represented by the formula (I-3-1) were mixed was added dropwise.
The results are shown in Table 1.

Figure 2013253041
Figure 2013253041

Figure 2013253041
Figure 2013253041

(実施例4)式(I−4)で表される化合物の製造 Example 4 Production of Compound Represented by Formula (I-4)

Figure 2013253041
Figure 2013253041

実施例3において式(I−3−1)で表される化合物を式(I−4−1)で表される化合物に置き換えた以外は実施例3と同様の方法によって、式(I−4)で表される化合物を製造した。収率79%、純度99.55%であった。
H NMR(DMSO−d)δ 2.11(m,4H),3.05(t,2H),4.15(t,2H),4.18(t,2H),4.28(m,4H),4.46(t,2H),5.96(d,2H),6.19(dd,2H),6.32(d,2H),7.04(d,2H),7.12(d,2H),7.19(d,2H),7.39(d,2H),7.88(d,2H),8.06(d,2H)ppm.
13C NMR(DMSO−d)δ 28.3,34.2,61.5,65.1,65.3,114.9,115.1,121.5,122.2,122.4,128.7,130.3,131.6,132.0,132.0,132.4,136.2,149.7,162.8,163.5,164.6,165.7,165.9ppm.
LRMS(EI) m/z 602(100).
(比較例7)
実施例4と同様の反応スケールで第一工程における試薬の加え方のみを、メタンスルホニルクロリドのテトラヒドロフラン溶液に対し、トリエチルアミンと式(I−4−1)で表される化合物を混合したテトラヒドロフラン溶液を滴下する方法に変更し、式(I−4)で表される化合物を製造した。収率76%、純度99.05%であった。
(実施例5)式(I−5)で表される化合物の製造
A compound of the formula (I-4) was prepared in the same manner as in Example 3 except that the compound represented by the formula (I-3-1) in Example 3 was replaced with the compound represented by the formula (I-4-1). ) Was produced. The yield was 79% and the purity was 99.55%.
1 H NMR (DMSO-d 6 ) δ 2.11 (m, 4H), 3.05 (t, 2H), 4.15 (t, 2H), 4.18 (t, 2H), 4.28 ( m, 4H), 4.46 (t, 2H), 5.96 (d, 2H), 6.19 (dd, 2H), 6.32 (d, 2H), 7.04 (d, 2H), 7.12 (d, 2H), 7.19 (d, 2H), 7.39 (d, 2H), 7.88 (d, 2H), 8.06 (d, 2H) ppm.
13 C NMR (DMSO-d 6 ) δ 28.3, 34.2, 61.5, 65.1, 65.3, 115.9, 115.1, 121.5, 122.2, 122.4 128.7, 130.3, 131.6, 132.0, 132.0, 132.4, 136.2, 149.7, 162.8, 163.5, 164.6, 165.7, 165. 9 ppm.
LRMS (EI) m / z 602 (100).
(Comparative Example 7)
A tetrahydrofuran solution in which triethylamine and a compound represented by the formula (I-4-1) were mixed with a tetrahydrofuran solution of methanesulfonyl chloride was added in the same reaction scale as in Example 4 except for adding the reagent in the first step. It changed into the method of dripping and the compound represented by Formula (I-4) was manufactured. The yield was 76% and the purity was 99.05%.
Example 5 Production of Compound Represented by Formula (I-5)

Figure 2013253041
Figure 2013253041

実施例4と同様の方法によって、式(I−4−2)で表される化合物を含む反応液を調製した。即ち、撹拌装置、温度計及び2つの滴下装置を備えた反応装置にメタンスルホニルクロリド5.00g(43.6ミリモル)及びテトラヒドロフラン10mLを加えた。氷冷しながら式(I−4−1)で表される化合物11.0g(44.1ミリモル)のテトラヒドロフラン溶液50mL及びトリエチルアミン5.25g(51.9ミリモル)のテトラヒドロフラン溶液25mLを各々別の滴下装置から(式(I−4−1)で表される化合物の溶液):(トリエチルアミン溶液)=2:1の滴下速度で同時に滴下した。   A reaction solution containing the compound represented by the formula (I-4-2) was prepared by the same method as in Example 4. That is, 5.00 g (43.6 mmol) of methanesulfonyl chloride and 10 mL of tetrahydrofuran were added to a reactor equipped with a stirrer, a thermometer and two dropping devices. While cooling with ice, 50 mL of a tetrahydrofuran solution of 11.0 g (44.1 mmol) of the compound represented by the formula (I-4-1) and 25 mL of a tetrahydrofuran solution of 5.25 g (51.9 mmol) of triethylamine were separately added dropwise. From the apparatus, (solution of the compound represented by the formula (I-4-1)) :( triethylamine solution) = 2: 1 at the same time.

その後氷冷しながら1時間撹拌した後、4−ジメチルアミノピリジン0.53g(4.3ミリモル)及びメチルヒドロキノン2.68g(21.6ミリモル)を加えた。氷冷しながらトリエチルアミン5.25g(51.9ミリモル)を滴下した。1時間撹拌した後、溶媒を留去し、ジクロロメタン及び5%塩酸を加え分液処理した。有機層を食塩水で洗浄し中和した後、カラムクロマトグラフィー(シリカゲル)及び再沈殿(ジクロロメタン/メタノール)により精製を行い、式(I−5)で表される化合物12.3gを得た。収率97%、純度99.73%であった。
H NMR(CDCl)δ 2.22(m,7H),4.17(t,4H),4.39(t,4H),5.85(d,2H),6.14(dd,2H),6.43(d,2H),6.99(dd,4H),7.08(dd,1H),7.14(d,1H),7.18(d,1H),8.16(dd,4H)ppm.
13C NMR(CDCl)δ 16.4,28.5,61.6,64.6,114.2,114.3,120.0,121.7,121.9,122.9,124.1,128.2,131.0,131.7,132.3,147.0,148.4,163.0,163.1,164.4,164.8,166.1ppm.
LRMS(EI) m/z 588(100).
(比較例8)
実施例5と同様の反応スケールで第一工程における試薬の加え方のみを、メタンスルホニルクロリドのテトラヒドロフラン溶液に対し、トリエチルアミンと式(I−4−1)で表される化合物を混合したテトラヒドロフラン溶液を滴下する方法に変更し、式(I−5)で表される化合物を製造した。収率93%、純度99.65%であった。
(実施例6)式(I−6)で表される化合物の製造
Thereafter, the mixture was stirred for 1 hour while cooling with ice, and 0.53 g (4.3 mmol) of 4-dimethylaminopyridine and 2.68 g (21.6 mmol) of methylhydroquinone were added. While cooling with ice, 5.25 g (51.9 mmol) of triethylamine was added dropwise. After stirring for 1 hour, the solvent was distilled off, and dichloromethane and 5% hydrochloric acid were added for liquid separation. The organic layer was washed with brine and neutralized, and then purified by column chromatography (silica gel) and reprecipitation (dichloromethane / methanol) to obtain 12.3 g of a compound represented by the formula (I-5). The yield was 97% and the purity was 99.73%.
1 H NMR (CDCl 3 ) δ 2.22 (m, 7H), 4.17 (t, 4H), 4.39 (t, 4H), 5.85 (d, 2H), 6.14 (dd, 2H), 6.43 (d, 2H), 6.99 (dd, 4H), 7.08 (dd, 1H), 7.14 (d, 1H), 7.18 (d, 1H), 8. 16 (dd, 4H) ppm.
13 C NMR (CDCl 3 ) δ 16.4, 28.5, 61.6, 64.6, 114.2, 114.3, 120.0, 121.7, 121.9, 122.9, 124. 1, 128.2, 131.0, 131.7, 132.3, 147.0, 148.4, 163.0, 163.1, 164.4, 164.8, 166.1 ppm.
LRMS (EI) m / z 588 (100).
(Comparative Example 8)
A tetrahydrofuran solution in which triethylamine and a compound represented by the formula (I-4-1) were mixed with a tetrahydrofuran solution of methanesulfonyl chloride only in the same manner as in Example 5 except that the reagent was added in the first step. It changed into the method of dripping and the compound represented by Formula (1-5) was manufactured. The yield was 93% and the purity was 99.65%.
Example 6 Production of Compound Represented by Formula (I-6)

Figure 2013253041
Figure 2013253041

撹拌装置、温度計及び2つの滴下装置を備えた反応容器にメタンスルホニルクロリド5.00g(43.6ミリモル)及びテトラヒドロフラン10mLを加えた。氷冷しながら4−アセトキシ安息香酸7.95g(44.1ミリモル)のテトラヒドロフラン溶液50mL及びトリエチルアミン5.25g(51.9ミリモル)のテトラヒドロフラン溶液25mLを各々別の滴下装置から(4−アセトキシ安息香酸の溶液):(トリエチルアミン溶液)=2:1の滴下速度で同時に滴下した。氷冷しながら30分間撹拌した後、4−ジメチルアミノピリジン0.53g(4.3ミリモル)及び2,4−ジメチルフェノール5.32g(43.6ミリモル)を加えた。氷冷しながらトリエチルアミン5.25g(51.9ミリモル)を滴下した。1時間撹拌した後、溶媒を留去し、ジクロロメタン及び5%塩酸を加え分液処理した。有機層を食塩水で洗浄し中和した後、カラムクロマトグラフィー(シリカゲル)及び再沈殿(ジクロロメタン/メタノール)により精製を行い、式(I−6−2)で表される化合物12.0g(42.2ミリモル)を得た。収率97%、純度99.85%であった。   To a reaction vessel equipped with a stirrer, a thermometer and two dropping devices, 5.00 g (43.6 mmol) of methanesulfonyl chloride and 10 mL of tetrahydrofuran were added. While cooling with ice, 50 mL of a tetrahydrofuran solution of 7.95 g (44.1 mmol) of 4-acetoxybenzoic acid and 25 mL of a tetrahydrofuran solution of 5.25 g (51.9 mmol) of triethylamine were respectively added from separate dropping devices (4-acetoxybenzoic acid). Solution) :( triethylamine solution) = 2 at the same time as the dropping speed of 2: 1. After stirring for 30 minutes while cooling with ice, 0.53 g (4.3 mmol) of 4-dimethylaminopyridine and 5.32 g (43.6 mmol) of 2,4-dimethylphenol were added. While cooling with ice, 5.25 g (51.9 mmol) of triethylamine was added dropwise. After stirring for 1 hour, the solvent was distilled off, and dichloromethane and 5% hydrochloric acid were added for liquid separation. The organic layer was washed with brine and neutralized, and then purified by column chromatography (silica gel) and reprecipitation (dichloromethane / methanol) to obtain 12.0 g (42 of compound represented by formula (I-6-2)) 0.2 mmol). The yield was 97% and the purity was 99.85%.

撹拌装置及び滴下装置を備えた反応容器に式(I−6−2)で表される化合物12.0g(42.2ミリモル)を加え、トルエン20mL及びテトラヒドロフラン20mLに溶解させた。ブチルアミン4.62g(63.3ミリモル)を滴下し室温で7時間撹拌した。5%塩酸及び食塩水で分液及び洗浄処理した後、再結晶(メタノール/水)により精製を行い、式(I−6−3)で表される化合物10.0g(41.3ミリモル)を得た。   12.0 g (42.2 mmol) of the compound represented by the formula (I-6-2) was added to a reaction vessel equipped with a stirrer and a dropping device, and dissolved in 20 mL of toluene and 20 mL of tetrahydrofuran. 4.62 g (63.3 mmol) of butylamine was added dropwise and stirred at room temperature for 7 hours. After separation and washing with 5% hydrochloric acid and brine, purification was performed by recrystallization (methanol / water), and 10.0 g (41.3 mmol) of the compound represented by the formula (I-6-3) was obtained. Obtained.

撹拌装置、温度計及び滴下装置を備えた反応容器に式(I−6−3)で表される化合物10.0g(41.3ミリモル)、式(I−4−1)で表される化合物10.3g(41.3ミリモル)及び4−ジメチルアミノピリジン0.50g(4.1ミリモル)を加え、ジクロロメタン50mLに懸濁させた。氷冷しながらN,N’−ジイソプロピルカルボジイミド6.25g(49.5ミリモル)を反応温度が15℃を超えないよう滴下した。室温で5時間撹拌した後、溶媒を留去しカラムクロマトグラフィー(シリカゲル)及び再沈殿(ジクロロメタン/メタノール)により精製を行い、式(I−6)で表される化合物16.9g(35.5ミリモル)を得た。
H NMR(CDCl)δ 2.19〜2.25(m,5H),2.34(s,3H),4.17(t,2H),4.39(t,2H),5.85(dd,1H),6.14(dd,1H),6.42(dd,1H),6.98〜7.08(m,5H),7.36(d,2H),8.16(d,2H),8.29(d,2H)ppm.
13C NMR(CDCl)δ 16.1,20.8,28.5,61.1,64.7,113.1,114.3,121.3,121.6,122.0,127.0,127.5,128.2,129.8,131.0,131.7,131.8,132.4,135.6,147.2,155.2,163.3,164.2,164.3,166.1ppm.
LRMS(EI)m/z 474(100)
(比較例9)
実施例6と同様の反応スケールで第一工程における試薬の加え方のみを、メタンスルホニルクロリドのテトラヒドロフラン溶液に対し、トリエチルアミンと4−アセトキシ安息香酸を混合したテトラヒドロフラン溶液を滴下する方法に変更し、式(I−6−2)で表される化合物を製造した。収率94%、純度99.68%であった。
10.0 g (41.3 mmol) of the compound represented by the formula (I-6-3) and the compound represented by the formula (I-4-1) in a reaction vessel equipped with a stirrer, a thermometer and a dropping device. 10.3 g (41.3 mmol) and 4-dimethylaminopyridine 0.50 g (4.1 mmol) were added and suspended in 50 mL of dichloromethane. While cooling with ice, 6.25 g (49.5 mmol) of N, N′-diisopropylcarbodiimide was added dropwise so that the reaction temperature did not exceed 15 ° C. After stirring at room temperature for 5 hours, the solvent was distilled off and the residue was purified by column chromatography (silica gel) and reprecipitation (dichloromethane / methanol) to obtain 16.9 g (35.5) of the compound represented by the formula (I-6). Mmol).
1 H NMR (CDCl 3 ) δ 2.19-2.25 (m, 5H), 2.34 (s, 3H), 4.17 (t, 2H), 4.39 (t, 2H), 5. 85 (dd, 1H), 6.14 (dd, 1H), 6.42 (dd, 1H), 6.98 to 7.08 (m, 5H), 7.36 (d, 2H), 8.16 (D, 2H), 8.29 (d, 2H) ppm.
13 C NMR (CDCl 3 ) δ 16.1, 20.8, 28.5, 61.1, 64.7, 113.1, 114.3, 121.3, 121.6, 122.0, 127. 0, 127.5, 128.2, 129.8, 131.0, 131.7, 131.8, 132.4, 135.6, 147.2, 155.2, 163.3, 164.2 164.3, 166.1 ppm.
LRMS (EI) m / z 474 (100)
(Comparative Example 9)
Only the method of adding the reagent in the first step with the same reaction scale as in Example 6 was changed to a method in which a tetrahydrofuran solution in which triethylamine and 4-acetoxybenzoic acid were mixed was dropped into a tetrahydrofuran solution of methanesulfonyl chloride. A compound represented by (I-6-2) was produced. The yield was 94% and the purity was 99.68%.

その後、実施例6と同様の方法によって式(I−6)で表される化合物を製造した。
(実施例7)式(I−7)で表される化合物(学術文献1記載の化合物)の製造
Thereafter, a compound represented by formula (I-6) was produced in the same manner as in Example 6.
(Example 7) Production of compound represented by formula (I-7) (compound described in Academic Literature 1)

Figure 2013253041
Figure 2013253041

学術文献1記載の方法によって式(I−7−1)で表される化合物を製造した。   A compound represented by formula (I-7-1) was produced by the method described in Academic Literature 1.

撹拌装置、温度計及び2つの滴下装置を備えた反応容器にクロロギ酸メチル11.6mL(150ミリモル)及びジクロロメタン50mLを加えた。氷冷しながら式(I−7−1)で表される化合物14g(75.2ミリモル)のテトラヒドロフラン溶液50mL及びトリエチルアミン21mL(150ミリモル)のテトラヒドロフラン溶液25mLを各々別の滴下装置から(式(I−7−1)で表される化合物の溶液):(トリエチルアミン溶液)=2:1の滴下速度で同時に滴下した。氷冷しながら2時間撹拌した後、溶媒を留去した。ジエチルエーテルに懸濁させ、濾過及び濃縮することにより式(I−7−2)で表される化合物17.1g(69.9ミリモル)を得た。   To a reaction vessel equipped with a stirrer, a thermometer and two dropping devices, 11.6 mL (150 mmol) of methyl chloroformate and 50 mL of dichloromethane were added. While cooling with ice, 50 mL of a tetrahydrofuran solution of 14 g (75.2 mmol) of the compound represented by the formula (I-7-1) and 25 mL of a tetrahydrofuran solution of 21 mL (150 mmol) of triethylamine were respectively added from separate dropping devices (formula (I The solution of the compound represented by -7-1)): (triethylamine solution) = 2: 1 was added dropwise at the same time. After stirring for 2 hours while cooling with ice, the solvent was distilled off. It was suspended in diethyl ether, filtered and concentrated to obtain 17.1 g (69.9 mmol) of a compound represented by the formula (I-7-2).

得られた式(I−7−2)で表される化合物17.1g(69.9ミリモル)を用いて学術文献1記載の方法によって還元し、式(I−7)で表される化合物7.82gを得た。収率65%、純度99.98%であった。得られた化合物のH NMR及びマススペクトルを測定した結果、非特許文献1記載の方法によって得られた化合物の測定データと一致した。
H NMR δ 5.86(m,1H),5.46(d,1H),5.28(d,1H),3.29(d,1H),2.44(s,1H),1.51(s,1H),1.44(s,3H),1.33(s,3H)ppm.
LRMS(EI) m/z 173,157,141,83,69.
(比較例10)非特許文献1記載の製法
非特許文献1記載の方法によって式(I−7−1)で表される化合物を製造した。
The compound 71 represented by the formula (I-7) was reduced by the method described in the academic literature 1 using 17.1 g (69.9 mmol) of the compound represented by the formula (I-7-2) obtained. .82 g was obtained. The yield was 65% and the purity was 99.98%. As a result of measuring 1 H NMR and mass spectrum of the obtained compound, it was consistent with the measurement data of the compound obtained by the method described in Non-Patent Document 1.
1 H NMR δ 5.86 (m, 1H), 5.46 (d, 1H), 5.28 (d, 1H), 3.29 (d, 1H), 2.44 (s, 1H), 1 .51 (s, 1H), 1.44 (s, 3H), 1.33 (s, 3H) ppm.
LRMS (EI) m / z 173, 157, 141, 83, 69.
(Comparative example 10) The manufacturing method of a nonpatent literature 1 The compound represented by Formula (I-7-1) by the method of the nonpatent literature 1 was manufactured.

撹拌装置、温度計及び滴下装置を備えた反応容器に式(I−7−1)で表される化合物14g(75.2ミリモル)のジクロロメタン溶液50mLに氷冷しながらトリエチルアミン21mL(150ミリモル)及びクロロギ酸メチル11.6mL(150ミリモル)を滴下した。氷冷しながら2時間撹拌した後、溶媒を留去した。ジエチルエーテルに懸濁させ、濾過及び濃縮することにより式(I−7−2)で表される化合物16.4gを得た。得られた式(I−7−2)で表される化合物16.4gを用いて非特許文献1記載の方法によって還元し、式(I−7)で表される化合物7.03gを得た。収率54%、純度99.34%であった。
(実施例8)式(I−8)で表される化合物(特許文献2記載の化合物)の製造
In a reaction vessel equipped with a stirrer, a thermometer and a dropping device, 21 mL (150 mmol) of triethylamine and 50 mL of a dichloromethane solution of 14 g (75.2 mmol) of the compound represented by the formula (I-7-1) were cooled with ice. 11.6 mL (150 mmol) of methyl chloroformate was added dropwise. After stirring for 2 hours while cooling with ice, the solvent was distilled off. 16.4 g of a compound represented by the formula (I-7-2) was obtained by suspending in diethyl ether, filtering and concentrating. Using 16.4 g of the compound represented by the formula (I-7-2) thus obtained, the compound was reduced by the method described in Non-Patent Document 1 to obtain 7.03 g of a compound represented by the formula (I-7). . The yield was 54% and the purity was 99.34%.
(Example 8) Production of compound represented by formula (I-8) (compound described in Patent Document 2)

Figure 2013253041
Figure 2013253041

特許文献2記載の製造方法において、3,4−ジ−(6−アクリロイルオキシヘキシルオキシ)安息香酸のテトラヒドロフラン溶液50mL及びジイソプロピルエチルアミンのテトラヒドロフラン溶液50mLを各々別の滴下装置から(3,4−ジ−(6−アクリロイルオキシヘキシルオキシ)安息香酸の溶液):(ジイソプロピルエチルアミン溶液)=1:1の滴下速度で同時に滴下した以外は同様の方法によって式(I−8)で表される化合物を製造した。収率46%、純度99.30%であった。得られた化合物のIRスペクトル、H NMR及びマススペクトルを測定した結果、特許文献2記載の方法によって得られた化合物の測定データと一致した。
IR(KBr) 2937,1717,1632,1598,1516,1495,1474,1410,1295,1265,1207,1189,1160,1078,992,812,756cm−1
H NMR δ 0.95(t,3H),1.50−1.91(m,18H),2.63(q,2H),4.08−4.21(m,8H),5.82−6.44(m,8H),6.70(d,1H),6.95(d,1H),7.41−7.17(m,4H),7.69(d,1H),7.73(d,1H),7.84−8.23(m,4H),8.82(s,1H)ppm.LRMS(EI)m/z 820(100).
(比較例11)特許文献2記載の製法
0℃以下で、メタンスルホン酸クロリドのテトラヒドロフラン溶液に対し、3,4−ジ−(6−アクリロイルオキシヘキシルオキシ)安息香酸及びジイソプロピルエチルアミンのテトラヒドロフラン溶液を滴下した。滴下終了後、そのまま30分間撹拌し、マイクロスパチュラ一片の4−ジメチルアミノピリジンとジイソプロピルエチルアミンとテトラヒドロフランの混合溶液を、−10℃以下に保ちながら滴下した。そのまま2時間撹拌を行った後に、反応液を水で洗浄し、1%塩酸とトルエンを加え、油水分離後、有機層を水で2回洗浄した。減圧下、溶媒を留去後、シリカゲルカラムクロマトグラフィー(展開溶媒:トルエン)で精製し、ついでメタノールより再沈殿を行い、析出物を濾過して式(I−8)で表される化合物を製造した。収率26%、純度99.31%であった。
(実施例9)式(I−9)で表される化合物(特許文献1記載の化合物)の製造
In the production method described in Patent Document 2, 50 mL of a tetrahydrofuran solution of 3,4-di- (6-acryloyloxyhexyloxy) benzoic acid and 50 mL of a tetrahydrofuran solution of diisopropylethylamine were respectively added from separate dropping devices (3,4-di- (6-acryloyloxyhexyloxy) benzoic acid solution): (diisopropylethylamine solution) = A compound represented by the formula (I-8) was produced by the same method except that it was dropped simultaneously at a dropping rate of 1: 1. . The yield was 46% and the purity was 99.30%. As a result of measuring the IR spectrum, 1 H NMR and mass spectrum of the obtained compound, it was consistent with the measurement data of the compound obtained by the method described in Patent Document 2.
IR (KBr) 2937, 1717, 1632, 1598, 1516, 1495, 1474, 1410, 1295, 1265, 1207, 1189, 1160, 1078, 992, 812, 756 cm −1 .
1 H NMR δ 0.95 (t, 3H), 1.50-1.91 (m, 18H), 2.63 (q, 2H), 4.08-4.21 (m, 8H), 5. 82-6.44 (m, 8H), 6.70 (d, 1H), 6.95 (d, 1H), 7.41-7.17 (m, 4H), 7.69 (d, 1H) , 7.73 (d, 1H), 7.84-8.23 (m, 4H), 8.82 (s, 1H) ppm. LRMS (EI) m / z 820 (100).
(Comparative Example 11) Process described in Patent Document 2 At 0 ° C. or lower, a tetrahydrofuran solution of 3,4-di- (6-acryloyloxyhexyloxy) benzoic acid and diisopropylethylamine was added dropwise to a tetrahydrofuran solution of methanesulfonic acid chloride. did. After completion of the dropwise addition, the mixture was stirred as it was for 30 minutes, and a mixed solution of 4-dimethylaminopyridine, diisopropylethylamine, and tetrahydrofuran in a piece of microspatula was added dropwise while maintaining at -10 ° C or lower. After stirring for 2 hours as it was, the reaction solution was washed with water, 1% hydrochloric acid and toluene were added, and after oil-water separation, the organic layer was washed twice with water. After distilling off the solvent under reduced pressure, the residue was purified by silica gel column chromatography (developing solvent: toluene), then reprecipitated from methanol, and the precipitate was filtered to produce a compound represented by the formula (I-8). did. The yield was 26% and the purity was 99.31%.
(Example 9) Production of compound represented by formula (I-9) (compound described in Patent Document 1)

Figure 2013253041
Figure 2013253041

特許文献1記載の製造方法において、式(I−3−1)で表される化合物のテトラヒドロフラン溶液300mL及びトリエチルアミンのテトラヒドロフラン溶液100mLを各々別の滴下装置から(式(I−3−1)で表される化合物の溶液):(トリエチルアミン溶液)=3:1の滴下速度で同時に滴下した以外は同様の方法によって式(I−9)で表される化合物を製造した。収率82%、純度99.35%であった。得られた化合物のH NMR及びマススペクトルを測定した結果、特許文献1記載の方法によって得られた化合物の測定データと一致した。
H NMR(CDCl) δ 8.70(s,2H),8.49(s,1H),8.18−8.11(m,4H),7.93(d,2H),7.40−7.26(m,4H),6.99(d,4H),6.41(d,2H),6.13(dd,2H),5.83(d,2H),4.20−4.06(m,8H),3.60(s,3H),1.85−1.70(m,8H),1.57−1.20(m,8H)ppm.
LRMS(EI) m/z 846(100).
(比較例12)
実施例9と同様のスケールで比較例1と同様の製造方法によって式(I−9)で表される化合物を製造した。収率72%、純度99.31%であった。
(実施例10)式(I−10)で表される化合物(EP0888281B1号公報記載の化合物)の製造
In the production method described in Patent Document 1, 300 mL of a tetrahydrofuran solution of the compound represented by the formula (I-3-1) and 100 mL of a tetrahydrofuran solution of triethylamine are respectively supplied from different dropping devices (represented by the formula (I-3-1)). The compound represented by the formula (I-9) was produced by the same method except that the solution was added dropwise at a dropping rate of 3: 1: (triethylamine solution) = 3: 1. The yield was 82% and the purity was 99.35%. As a result of measuring 1 H NMR and mass spectrum of the obtained compound, it was consistent with the measurement data of the compound obtained by the method described in Patent Document 1.
1 H NMR (CDCl 3 ) δ 8.70 (s, 2H), 8.49 (s, 1H), 8.18-8.11 (m, 4H), 7.93 (d, 2H), 7. 40-7.26 (m, 4H), 6.99 (d, 4H), 6.41 (d, 2H), 6.13 (dd, 2H), 5.83 (d, 2H), 4.20 -4.06 (m, 8H), 3.60 (s, 3H), 1.85-1.70 (m, 8H), 1.57-1.20 (m, 8H) ppm.
LRMS (EI) m / z 846 (100).
(Comparative Example 12)
A compound represented by the formula (I-9) was produced on the same scale as in Example 9 by the same production method as in Comparative Example 1. The yield was 72% and the purity was 99.31%.
(Example 10) Production of a compound represented by the formula (I-10) (compound described in EP 0888281B1)

Figure 2013253041
Figure 2013253041

実施例3と同様の方法によって式(I−3−2)で表される化合物の溶液を調製した。即ち、撹拌装置、温度計及び2つの滴下装置を備えた反応装置にメタンスルホニルクロリド5.00g(43.6ミリモル)及びテトラヒドロフラン10mLを加えた。氷冷しながら式(I−3−1)で表される化合物12.9g(44.1ミリモル)のテトラヒドロフラン溶液60mL及びトリエチルアミン5.25g(51.9ミリモル)のテトラヒドロフラン溶液30mLを各々別の滴下装置から(式(I−3−1)で表される化合物の溶液):(トリエチルアミン溶液)=2:1の滴下速度で同時に滴下した。   A solution of the compound represented by formula (I-3-2) was prepared in the same manner as in Example 3. That is, 5.00 g (43.6 mmol) of methanesulfonyl chloride and 10 mL of tetrahydrofuran were added to a reactor equipped with a stirrer, a thermometer and two dropping devices. While cooling with ice, 60 mL of a tetrahydrofuran solution of 12.9 g (44.1 mmol) of the compound represented by formula (I-3-1) and 30 mL of a tetrahydrofuran solution of 5.25 g (51.9 mmol) of triethylamine were separately added dropwise. From the apparatus, (solution of the compound represented by the formula (I-3-1)) :( triethylamine solution) = 2: 1 at the same time.

その後、氷冷しながら1時間撹拌した後、4−ジメチルアミノピリジン0.54g(4.41ミリモル)及び式(I−10−1)で表される化合物9.52g(43.6ミリモル)を加えた。氷冷しながらトリエチルアミン5.25g(51.9ミリモル)を滴下した。3時間撹拌した後、溶媒を留去し、ジクロロメタン及び5%塩酸を加え分液処理した。有機層を食塩水で洗浄し中和した後、カラムクロマトグラフィー(シリカゲル)及び再沈殿(ジクロロメタン/メタノール)により精製を行い、式(I−10)で表される化合物19.5gを得た。収率91%、純度99.43%であった。得られた化合物のH NMR、13C NMR及びマススペクトルを測定した結果、特表2000−507932号公報記載の方法によって得られた化合物の測定データと一致した。
H NMR(CDCl)δ 0.91(t,3H),1.09(m,2H),1.19−1.54(m,12H),1.73(quin,2H),1.86(m,6H),2.49(t,1H),4.05(t,2H),4.18(t,2H),5.82(d,1H),6.12(dd,1H),6.40(d,1H),6.95(d,2H),7.10(d,2H),7.24(d,2H),8.13(d,2H)ppm.
13C NMR(CDCl)δ 14.4,20.0,25.7,25.7,28.5,29.0,33.5,34.4,37.0,39.7,44.1,64.4,68.0,114.2,121.3,121.8,127.7,128.5,130.5,132.2,145.2,148.9,163.3,165.1,166.3ppm.
LRMS(EI) m/z 492(100).
(比較例13)
実施例10と同様のスケールで、式(I−3−1)で表される化合物及びトリエチルアミンを混合したテトラヒドロフラン溶液を滴下した以外は実施例10と同様の方法によって式(I−10)で表される化合物を製造した。収率87%、純度99.41%であった。
(比較例14)EP0888281B1号公報記載の製法
実施例10と同様のスケールで、EP0888281B1号公報記載の方法によって式(I−10)で表される化合物を製造した。収率70%、純度99.01%であった。
(実施例11)式(I−11)で表される化合物(EP1786887B1号公報記載の化合物)の製造
Then, after stirring for 1 hour while cooling with ice, 0.54 g (4.41 mmol) of 4-dimethylaminopyridine and 9.52 g (43.6 mmol) of the compound represented by the formula (I-10-1) were added. added. While cooling with ice, 5.25 g (51.9 mmol) of triethylamine was added dropwise. After stirring for 3 hours, the solvent was distilled off, and dichloromethane and 5% hydrochloric acid were added for liquid separation. The organic layer was washed with brine and neutralized, and then purified by column chromatography (silica gel) and reprecipitation (dichloromethane / methanol) to obtain 19.5 g of a compound represented by the formula (I-10). The yield was 91% and the purity was 99.43%. As a result of measuring 1 H NMR, 13 C NMR and mass spectrum of the obtained compound, it was consistent with the measurement data of the compound obtained by the method described in JP 2000-507932 A.
1 H NMR (CDCl 3 ) δ 0.91 (t, 3H), 1.09 (m, 2H), 1.19-1.54 (m, 12H), 1.73 (quin, 2H), 1. 86 (m, 6H), 2.49 (t, 1H), 4.05 (t, 2H), 4.18 (t, 2H), 5.82 (d, 1H), 6.12 (dd, 1H) ), 6.40 (d, 1H), 6.95 (d, 2H), 7.10 (d, 2H), 7.24 (d, 2H), 8.13 (d, 2H) ppm.
13 C NMR (CDCl 3 ) δ 14.4, 20.0, 25.7, 25.7, 28.5, 29.0, 33.5, 34.4, 37.0, 39.7, 44. 1, 64.4, 68.0, 114.2, 121.3, 121.8, 127.7, 128.5, 130.5, 132.2, 145.2, 148.9, 163.3 165.1, 166.3 ppm.
LRMS (EI) m / z 492 (100).
(Comparative Example 13)
It is represented by the formula (I-10) by the same method as in Example 10, except that a tetrahydrofuran solution in which the compound represented by the formula (I-3-1) and triethylamine are mixed is dropped on the same scale as in Example 10. The resulting compound was prepared. The yield was 87% and the purity was 99.41%.
(Comparative Example 14) Production method described in EP0888281B1 A compound represented by the formula (I-10) was produced by the method described in EP0888281B1 on the same scale as in Example 10. The yield was 70% and the purity was 99.01%.
(Example 11) Production of compound represented by formula (I-11) (compound described in EP 1786888B1)

Figure 2013253041
Figure 2013253041

実施例10において、式(I−10−1)で表される化合物を式(I−11−1)で置き換えた以外は実施例10と同様の方法によって、式(I−11)で表される化合物を製造した。収率87%、純度99.41%であった。得られた化合物のH NMR、13C NMR及びマススペクトルを測定した結果、EP1786887B1号公報記載の方法によって得られた化合物の測定データと一致した。
H NMR(CDCl)δ 1.51(m,4H),1.73(quin,2H),1.85(quin,2H),3.84(s,3H),4.06(t,2H),4.19(t,2H),5.82(d,1H),6.12(dd,1H),6.40(d,1H),6.89(d,2H),6.98(d,2H),7.25(d,1H),7.43(m,3H),7.62(d,1H),8.17(d,2H)ppm.
13C NMR(CDCl)δ 25.7,25.7,28.5,28.9,55.3,64.4,68.1,86.2,90.5,114.0,114.4,114.7,120.7,122.6,123.9,127.1,128.5,130.5,130.7,132.5,132.9,133.1,147.0,159.9,163.7,163.8,166.3ppm.
LRMS(EI) m/z 532(100).
(比較例15)
実施例11と同様のスケールで、式(I−3−1)で表される化合物及びトリエチルアミンを混合したテトラヒドロフラン溶液を滴下した以外は実施例11と同様の方法によって式(I−11)で表される化合物を製造した。収率85%、純度99.40%であった。
(比較例16)EP1786887B1号公報記載の製法
実施例11と同様のスケールで、EP1786887B1号公報記載の方法によって式(I−11)で表される化合物を製造した。収率65%、純度98.60%であった。
(実施例12)式(I−12)で表される化合物(WO2009−060843号公報に記載の化合物)の製造
In Example 10, the compound represented by formula (I-11-1) was represented by formula (I-11) by the same method as in Example 10 except that the compound represented by formula (I-10-1) was replaced by formula (I-11-1). A compound was prepared. The yield was 87% and the purity was 99.41%. As a result of measuring 1 H NMR, 13 C NMR and mass spectrum of the obtained compound, it was consistent with the measurement data of the compound obtained by the method described in EP178688B1.
1 H NMR (CDCl 3 ) δ 1.51 (m, 4H), 1.73 (quin, 2H), 1.85 (quin, 2H), 3.84 (s, 3H), 4.06 (t, 2H), 4.19 (t, 2H), 5.82 (d, 1H), 6.12 (dd, 1H), 6.40 (d, 1H), 6.89 (d, 2H), 6. 98 (d, 2H), 7.25 (d, 1H), 7.43 (m, 3H), 7.62 (d, 1H), 8.17 (d, 2H) ppm.
13 C NMR (CDCl 3 ) δ 25.7, 25.7, 28.5, 28.9, 55.3, 64.4, 68.1, 86.2, 90.5, 114.0, 114. 4, 114.7, 120.7, 122.6, 123.9, 127.1, 128.5, 130.5, 130.7, 132.5, 132.9, 133.1, 147.0, 159.9, 163.7, 163.8, 166.3 ppm.
LRMS (EI) m / z 532 (100).
(Comparative Example 15)
It is represented by the formula (I-11) by the same method as in Example 11 except that a tetrahydrofuran solution in which the compound represented by the formula (I-3-1) and triethylamine are mixed is dropped on the same scale as in the example 11. The resulting compound was prepared. The yield was 85% and the purity was 99.40%.
(Comparative Example 16) Production method described in EP178688B1 A compound represented by the formula (I-11) was produced by the method described in EP178688B1 on the same scale as in Example 11. The yield was 65% and the purity was 98.60%.
(Example 12) Production of compound represented by formula (I-12) (compound described in WO2009-060843)

Figure 2013253041
Figure 2013253041

撹拌装置、温度計及び2つの滴下装置を備えた反応容器にメタンスルホニルクロリド5.00g(43.6ミリモル)及びジクロロメタン10mLを加えた。氷冷しながら式(I−12−1)で表される化合物5.72g(43.6ミリモル)のテトラヒドロフラン溶液20mL及びトリエチルアミン5.29g(52.3ミリモル)のテトラヒドロフラン溶液20mLを各々別の滴下装置から(式(I−12−1)で表される化合物の溶液):(トリエチルアミン溶液)=1:1の滴下速度で同時に滴下した。氷冷しながら30分間撹拌した後、4−ジメチルアミノピリジン0.53g(4.3ミリモル)及び式(I−12−2)で表される化合物8.43g(43.6ミリモル)を加えた。氷冷しながらトリエチルアミン5.29g(52.3ミリモル)を滴下した。1時間撹拌した後、溶媒を留去し、ジクロロメタン及び5%塩酸を加え分液処理した。有機層を食塩水で洗浄し中和した後、カラムクロマトグラフィー(シリカゲル)により精製を行い、式(I−12)で表される化合物11.2g(42.2ミリモル)を得た。収率84%、純度99.93%であった。得られた化合物のH NMR、13C NMR及びマススペクトルを測定した結果、WO2009−060843号公報に記載の方法によって得られた化合物の測定データと一致した。
(比較例17)
実施例12と同様のスケールで、式(I−12−1)で表される化合物及びトリエチルアミンを混合したテトラヒドロフラン溶液を滴下した以外は実施例12と同様の方法によって式(I−12)で表される化合物を製造した。収率82%、純度99.90%であった。
(実施例13)式(I−13)で表される化合物(Journal of the American Chemical Society,131巻,p.3812−3813(2009年)記載の化合物)の製造
To a reaction vessel equipped with a stirrer, a thermometer, and two dropping devices, 5.00 g (43.6 mmol) of methanesulfonyl chloride and 10 mL of dichloromethane were added. While cooling with ice, 20 mL of a tetrahydrofuran solution of 5.72 g (43.6 mmol) of the compound represented by the formula (I-12-1) and 20 mL of a tetrahydrofuran solution of 5.29 g (52.3 mmol) of triethylamine were separately added dropwise. The solution was dropped simultaneously at a dropping rate of (solution of compound represented by formula (I-12-1)) :( triethylamine solution) = 1: 1 from the apparatus. After stirring for 30 minutes while cooling with ice, 0.53 g (4.3 mmol) of 4-dimethylaminopyridine and 8.43 g (43.6 mmol) of the compound represented by the formula (I-12-2) were added. . While cooling with ice, 5.29 g (52.3 mmol) of triethylamine was added dropwise. After stirring for 1 hour, the solvent was distilled off, and dichloromethane and 5% hydrochloric acid were added for liquid separation. The organic layer was washed with brine and neutralized, and then purified by column chromatography (silica gel) to obtain 11.2 g (42.2 mmol) of the compound represented by formula (I-12). The yield was 84% and the purity was 99.93%. As a result of measuring 1 H NMR, 13 C NMR and mass spectrum of the obtained compound, it was consistent with the measurement data of the compound obtained by the method described in WO2009-060843.
(Comparative Example 17)
It is represented by the formula (I-12) by the same method as in Example 12, except that a tetrahydrofuran solution in which the compound represented by the formula (I-12-1) and triethylamine are mixed is dropped on the same scale as in Example 12. The resulting compound was prepared. The yield was 82% and the purity was 99.90%.
(Example 13) Production of compound represented by formula (I-13) (compound described in Journal of the American Chemical Society, vol. 131, p. 3812-3813 (2009))

Figure 2013253041
Figure 2013253041

撹拌装置、温度計及び2つの滴下装置を備えた反応容器にメタンスルホニルクロリド7.50g(65.5ミリモル)及びジクロロメタン10mLを加えた。氷冷しながら式(I−13−1)で表される化合物37.5g(66.2ミリモル)のジクロロメタン溶液120mL及びトリエチルアミン7.29g(72.1ミリモル)のジクロロメタン溶液60mLを各々別の滴下装置から(式(I−13−1)で表される化合物の溶液):(トリエチルアミン溶液)=2:1の滴下速度で同時に滴下した。氷冷しながら30分間撹拌した後、4−ジメチルアミノピリジン0.80g(6.6ミリモル)及び式(I−13−2)で表される化合物7.50g(62.9ミリモル)を加えた。氷冷しながらトリエチルアミン7.29g(72.1ミリモル)を滴下した。1時間撹拌した後、溶媒を留去し、カラムクロマトグラフィー(シリカゲル)により精製を行い、式(I−13)で表される化合物36.9gを得た。収率88%、純度99.91%であった。得られた化合物のH NMR、13C NMR及びマススペクトルを測定した結果、Journal of the American Chemical Society,131巻,p.3812−3813(2009年)記載の方法で得られた化合物の測定データと一致した。
H NMR(C)δ 7.82(s,1H),7.15(s,1H),6.90(s,1H),6.78(1H),6.69(dd,1H),5.82(d,1H),5.65(dd,1H),4.22(m,4H),4.16(d,1H),3.24(m,1H),3.14(m,1H),3.12(s,3H),3.02(s,2H),2.80(m,1H),2.66(m,1H),1.49(s,3H),1.47(s,3H),0.94(m,4H),−0.07(s,9H),−0.11(s,9H)ppm.
13C NMR (C)δ 201.1,169.3,154.1,153.7,152.6,141.7,140.5,139.8,130.5,126.7,126.2,116.5,116.0,110.1,88.2,67.0,63.3,57.7,46.2,39.7,27.6,22.7,18.0,17.6,16.4,−1.6,−1.7ppm.
LRMS(EI) m/z 666(100).
(比較例18)
実施例13と同様のスケールで、式(I−13−1)で表される化合物及びトリエチルアミンを混合したジクロロメタン溶液を滴下した以外は実施例13と同様の方法によって式(I−13)で表される化合物を製造した。収率85%、純度99.88%であった。
(実施例14)式(I−14)で表される化合物の製造
To a reaction vessel equipped with a stirrer, a thermometer and two dropping devices, 7.50 g (65.5 mmol) of methanesulfonyl chloride and 10 mL of dichloromethane were added. While cooling with ice, 120 mL of a solution of 37.5 g (66.2 mmol) of the compound represented by the formula (I-13-1) and 60 mL of a dichloromethane solution of 7.29 g (72.1 mmol) of triethylamine were separately added dropwise. From the apparatus, (solution of the compound represented by the formula (I-13-1)) :( triethylamine solution) = 2: 1 at the same time. After stirring for 30 minutes while cooling with ice, 0.80 g (6.6 mmol) of 4-dimethylaminopyridine and 7.50 g (62.9 mmol) of the compound represented by the formula (I-13-2) were added. . While cooling with ice, 7.29 g (72.1 mmol) of triethylamine was added dropwise. After stirring for 1 hour, the solvent was distilled off and the residue was purified by column chromatography (silica gel) to obtain 36.9 g of a compound represented by the formula (I-13). The yield was 88% and the purity was 99.91%. As a result of measuring 1 H NMR, 13 C NMR and mass spectrum of the obtained compound, Journal of the American Chemical Society, vol. 131, p. This coincided with the measurement data of the compound obtained by the method described in 3812-3813 (2009).
1 H NMR (C 6 D 6 ) δ 7.82 (s, 1H), 7.15 (s, 1H), 6.90 (s, 1H), 6.78 (1H), 6.69 (dd, 1H), 5.82 (d, 1H), 5.65 (dd, 1H), 4.22 (m, 4H), 4.16 (d, 1H), 3.24 (m, 1H), 3. 14 (m, 1H), 3.12 (s, 3H), 3.02 (s, 2H), 2.80 (m, 1H), 2.66 (m, 1H), 1.49 (s, 3H) ), 1.47 (s, 3H), 0.94 (m, 4H), -0.07 (s, 9H), -0.11 (s, 9H) ppm.
13 C NMR (C 6 D 6 ) δ 201.1, 169.3, 154.1, 153.7, 152.6, 141.7, 140.5, 139.8, 130.5, 126.7, 126.2, 116.5, 116.0, 110.1, 88.2, 67.0, 63.3, 57.7, 46.2, 39.7, 27.6, 22.7, 18. 0, 17.6, 16.4, -1.6, -1.7 ppm.
LRMS (EI) m / z 666 (100).
(Comparative Example 18)
It is represented by the formula (I-13) by the same method as in Example 13 except that a dichloromethane solution in which the compound represented by the formula (I-13-1) and triethylamine are mixed is dropped on the same scale as in Example 13. The resulting compound was prepared. The yield was 85% and the purity was 99.88%.
Example 14 Production of Compound Represented by Formula (I-14)

Figure 2013253041
Figure 2013253041

撹拌装置、冷却器及び温度計を備えた反応容器に6−ヒドロキシ−2−ナフトエ酸(式(I−14−1)で表される化合物) 100g(0.53モル)、酢酸300mL、無水酢酸65.1g(0.64モル)、硫酸5gを加え、60℃に加熱し8時間反応させた。反応液に水1Lを加え氷冷しながら1時間撹拌した後、析出した固体を濾過した。得られた固体を水1Lで2度分散洗浄した。固体を乾燥させることにより式(I−14−2)で表される化合物 118.7gを得た。   In a reaction vessel equipped with a stirrer, a cooler, and a thermometer, 100 g (0.53 mol) of 6-hydroxy-2-naphthoic acid (a compound represented by the formula (I-14-1)), 300 mL of acetic acid, acetic anhydride 65.1 g (0.64 mol) and 5 g of sulfuric acid were added, heated to 60 ° C. and reacted for 8 hours. After adding 1 L of water to the reaction solution and stirring for 1 hour while cooling with ice, the precipitated solid was filtered. The obtained solid was dispersed and washed twice with 1 L of water. The solid was dried to obtain 118.7 g of a compound represented by the formula (I-14-2).

撹拌装置、温度計及び2つの滴下装置を備えた反応容器にメタンスルホニルクロリド5.00g(43.6ミリモル)及びテトラヒドロフラン10mLを加えた。氷冷しながら式(I−14−2)で表される化合物10.2g(44.1ミリモル)のテトラヒドロフラン溶液50mL及びトリエチルアミン5.25g(51.9ミリモル)のテトラヒドロフラン溶液25mLを各々別の滴下装置から(4−アセトキシ安息香酸の溶液):(トリエチルアミン溶液)=2:1の滴下速度で同時に滴下した。氷冷しながら30分間撹拌した後、4−ジメチルアミノピリジン0.53g(4.3ミリモル)及び2,4−ジメチルフェノール5.32g(43.6ミリモル)を加えた。氷冷しながらトリエチルアミン5.25g(51.9ミリモル)を滴下した。1時間撹拌した後、溶媒を留去し、ジクロロメタン及び5%塩酸を加え分液処理した。有機層を食塩水で洗浄し中和した後、カラムクロマトグラフィー(シリカゲル)及び再沈殿(ジクロロメタン/メタノール)により精製を行い、式(I−14−4)で表される化合物14.1g(42.2ミリモル)を得た。収率97%、純度99.57%であった。   To a reaction vessel equipped with a stirrer, a thermometer and two dropping devices, 5.00 g (43.6 mmol) of methanesulfonyl chloride and 10 mL of tetrahydrofuran were added. While cooling with ice, 50 mL of a tetrahydrofuran solution of 10.2 g (44.1 mmol) of the compound represented by the formula (I-14-2) and 25 mL of a tetrahydrofuran solution of 5.25 g (51.9 mmol) of triethylamine were separately added dropwise. From the apparatus, (4-acetoxybenzoic acid solution) :( triethylamine solution) was simultaneously added dropwise at a dropping rate of 2: 1. After stirring for 30 minutes while cooling with ice, 0.53 g (4.3 mmol) of 4-dimethylaminopyridine and 5.32 g (43.6 mmol) of 2,4-dimethylphenol were added. While cooling with ice, 5.25 g (51.9 mmol) of triethylamine was added dropwise. After stirring for 1 hour, the solvent was distilled off, and dichloromethane and 5% hydrochloric acid were added for liquid separation. The organic layer was washed with brine and neutralized, and then purified by column chromatography (silica gel) and reprecipitation (dichloromethane / methanol) to obtain 14.1 g (42) of the compound represented by the formula (I-14-4) 0.2 mmol). The yield was 97% and the purity was 99.57%.

撹拌装置及び滴下装置を備えた反応容器に式(I−14−4)で表される化合物14.1g(42.2ミリモル)を加え、トルエン30mL及びテトラヒドロフラン30mLに溶解させた。ブチルアミン4.62g(63.3ミリモル)を滴下し室温で7時間撹拌した。5%塩酸及び食塩水で分液及び洗浄処理した後、再結晶(メタノール/水)により精製を行い、式(I−14−5)で表される化合物12.1g(41.3ミリモル)を得た。   14.1 g (42.2 mmol) of the compound represented by the formula (I-14-4) was added to a reaction vessel equipped with a stirrer and a dropping device, and dissolved in 30 mL of toluene and 30 mL of tetrahydrofuran. 4.62 g (63.3 mmol) of butylamine was added dropwise and stirred at room temperature for 7 hours. After separation and washing with 5% hydrochloric acid and brine, purification was performed by recrystallization (methanol / water) to obtain 12.1 g (41.3 mmol) of the compound represented by the formula (I-14-5). Obtained.

撹拌装置、温度計及び2つの滴下装置を備えた反応容器にメタンスルホニルクロリド4.73g(41.3ミリモル)及びテトラヒドロフラン10mLを加えた。氷冷しながら式(I−14−6)で表される化合物10.3g(41.3ミリモル)のテトラヒドロフラン溶液50mL及びトリエチルアミン5.25g(51.9ミリモル)のテトラヒドロフラン溶液25mLを各々別の滴下装置から(4−アセトキシ安息香酸の溶液):(トリエチルアミン溶液)=2:1の滴下速度で同時に滴下した。氷冷しながら30分間撹拌した後、4−ジメチルアミノピリジン0.53g(4.3ミリモル)及び式(I−14−5)で表される化合物12.1g(41.3ミリモル)を加えた。氷冷しながらトリエチルアミン5.25g(51.9ミリモル)を滴下した。1時間撹拌した後、溶媒を留去し、ジクロロメタン及び5%塩酸を加え分液処理した。有機層を食塩水で洗浄し中和した後、カラムクロマトグラフィー(シリカゲル)及び再沈殿(ジクロロメタン/メタノール)により精製を行い、式(I−14)で表される化合物20.8g(39.6ミリモル)を得た。収率96%、純度99.68%であった。
H NMR(CDCl)δ 2.20〜2.26(m,5H),2.35(s,3H),4.18(t,2H),4.40(t,2H),5.85(dd,1H),6.14(dd,1H),6.43(dd,1H),7.01(d,2H),7.07(s,2H),7.11(s,1H),7.46(dd,1H),7.77(d,1H),7.93(d,1H),8.06(d,1H),8.20(d,2H),8.24(dd,1H),8.82(d,1H)ppm.
13C NMR(CDCl)δ 16.2,20.8,28.5,61.1,64.7,114.3,118.8,121.6,121.6,122.5,126.2,126.6,127.5,128.1,128.2,129.8,130.4,131.0,131.6,131.8,132.4,135.7,136.4,147.3,150.8,163.2,164.7,165.0,166.1ppm.
LRMS(EI)m/z 524(100).
(比較例19)
実施例14と同様の反応スケールで式(I−14−4)で表される化合物を得る工程及び、式(I−14)で表される化合物を得る工程における試薬の加え方のみを、メタンスルホニルクロリドのテトラヒドロフラン溶液に対し、トリエチルアミン及びカルボン酸を混合したテトラヒドロフラン溶液を滴下する方法に変更し、式(I−14)で表される化合物を製造した。各々の工程において得られた化合物は、収率95%、純度98.57%及び、収率92%、純度99.37%であった。
(実施例15)式(I−14)で表される化合物の製造
To a reaction vessel equipped with a stirrer, a thermometer, and two dropping devices, 4.73 g (41.3 mmol) of methanesulfonyl chloride and 10 mL of tetrahydrofuran were added. While cooling with ice, 50 mL of a tetrahydrofuran solution of 10.3 g (41.3 mmol) of the compound represented by the formula (I-14-6) and 25 mL of a tetrahydrofuran solution of 5.25 g (51.9 mmol) of triethylamine were separately added dropwise. From the apparatus, (4-acetoxybenzoic acid solution) :( triethylamine solution) was simultaneously added dropwise at a dropping rate of 2: 1. After stirring for 30 minutes while cooling with ice, 0.53 g (4.3 mmol) of 4-dimethylaminopyridine and 12.1 g (41.3 mmol) of the compound represented by the formula (I-14-5) were added. . While cooling with ice, 5.25 g (51.9 mmol) of triethylamine was added dropwise. After stirring for 1 hour, the solvent was distilled off, and dichloromethane and 5% hydrochloric acid were added for liquid separation. The organic layer was washed with brine and neutralized, and then purified by column chromatography (silica gel) and reprecipitation (dichloromethane / methanol) to obtain 20.8 g (39.6) of the compound represented by the formula (I-14). Mmol). The yield was 96% and the purity was 99.68%.
1 H NMR (CDCl 3 ) δ 2.20 to 2.26 (m, 5H), 2.35 (s, 3H), 4.18 (t, 2H), 4.40 (t, 2H), 5. 85 (dd, 1H), 6.14 (dd, 1H), 6.43 (dd, 1H), 7.01 (d, 2H), 7.07 (s, 2H), 7.11 (s, 1H ), 7.46 (dd, 1H), 7.77 (d, 1H), 7.93 (d, 1H), 8.06 (d, 1H), 8.20 (d, 2H), 8.24 (Dd, 1H), 8.82 (d, 1H) ppm.
13 C NMR (CDCl 3 ) δ 16.2, 20.8, 28.5, 61.1, 64.7, 114.3, 118.8, 121.6, 121.6, 122.5, 126. 2, 126.6, 127.5, 128.1, 128.2, 129.8, 130.4, 131.0, 131.6, 131.8, 132.4, 135.7, 136.4. 147.3, 150.8, 163.2, 164.7, 165.0, 166.1 ppm.
LRMS (EI) m / z 524 (100).
(Comparative Example 19)
Only in the step of obtaining the compound represented by formula (I-14-4) on the same reaction scale as in Example 14 and the step of obtaining the compound represented by formula (I-14), the addition of the reagent The method was changed to a method in which a tetrahydrofuran solution in which triethylamine and carboxylic acid were mixed was added dropwise to a tetrahydrofuran solution of sulfonyl chloride, to produce a compound represented by the formula (I-14). The compound obtained in each step had a yield of 95%, a purity of 98.57%, and a yield of 92% and a purity of 99.37%.
Example 15 Production of Compound Represented by Formula (I-14)

Figure 2013253041
Figure 2013253041

実施例3と同様の方法によって式(I−3−2)で表される化合物の溶液を調製した。即ち、撹拌装置、温度計及び2つの滴下装置を備えた反応装置にメタンスルホニルクロリド5.00g(43.6ミリモル)及びテトラヒドロフラン10mLを加えた。氷冷しながら式(I−3−1)で表される化合物12.9g(44.1ミリモル)のテトラヒドロフラン溶液60mL及びトリエチルアミン5.25g(51.9ミリモル)のテトラヒドロフラン溶液30mLを各々別の滴下装置から(式(I−3−1)で表される化合物の溶液):(トリエチルアミン溶液)=2:1の滴下速度で同時に滴下した。   A solution of the compound represented by formula (I-3-2) was prepared in the same manner as in Example 3. That is, 5.00 g (43.6 mmol) of methanesulfonyl chloride and 10 mL of tetrahydrofuran were added to a reactor equipped with a stirrer, a thermometer and two dropping devices. While cooling with ice, 60 mL of a tetrahydrofuran solution of 12.9 g (44.1 mmol) of the compound represented by formula (I-3-1) and 30 mL of a tetrahydrofuran solution of 5.25 g (51.9 mmol) of triethylamine were separately added dropwise. From the apparatus, (solution of the compound represented by the formula (I-3-1)) :( triethylamine solution) = 2: 1 at the same time.

その後、氷冷しながら1時間撹拌した後、4−ジメチルアミノピリジン0.54g(4.41ミリモル)及び式(I−6−3)で表される化合物10.6g(43.6ミリモル)を加えた。氷冷しながらトリエチルアミン5.25g(51.9ミリモル)を滴下した。3時間撹拌した後、溶媒を留去し、ジクロロメタン及び5%塩酸を加え分液処理した。有機層を食塩水で洗浄し中和した後、カラムクロマトグラフィー(シリカゲル)及び再沈殿(ジクロロメタン/メタノール)により精製を行い、式(I−15)で表される化合物21.6gを得た。収率96%、純度99.55%であった。
H NMR(CDCl)δ 1.45〜1.57(m,4H),1.73(quin,2H),1.85(quin,2H),2.19(s,3H),2.34(s,3H),4.06(t,2H),4.18(t,2H),5.82(dd,1H),6.12(dd,1H),6.41(dd,1H),6.97〜7.08(m,5H),7.36(d,2H),8.15(d,2H),8.29(d,2H)ppm.
13C NMR(CDCl)δ 16.1,20.8,25.6,25.7,28.5,28.9,64.4,68.1,114.3,121.0,121.6,122.0,126.9,127.2,127.5,128.5,129.8,130.5,131.7,131.8,132.4,135.6,147.2,155.2,163.7,164.3,164.3,166.3ppm.
LRMS(EI)m/z 516(100).
(比較例20)
実施例15と同様のスケールで、式(I−3−1)で表される化合物及びトリエチルアミンを混合したテトラヒドロフラン溶液を滴下した以外は実施例15と同様の方法によって式(I−15)で表される化合物を製造した。収率88%、純度99.43%であった。
(実施例16〜25及び比較例21〜33)フィルムの評価
下記化合物(A):30%、化合物(B):40%及び化合物(C):30%からなる母体組成物(M)を調製した。
Then, after stirring for 1 hour while cooling with ice, 0.54 g (4.41 mmol) of 4-dimethylaminopyridine and 10.6 g (43.6 mmol) of the compound represented by the formula (I-6-3) were added. added. While cooling with ice, 5.25 g (51.9 mmol) of triethylamine was added dropwise. After stirring for 3 hours, the solvent was distilled off, and dichloromethane and 5% hydrochloric acid were added for liquid separation. The organic layer was washed with brine and neutralized, and then purified by column chromatography (silica gel) and reprecipitation (dichloromethane / methanol) to obtain 21.6 g of a compound represented by the formula (I-15). The yield was 96% and the purity was 99.55%.
1 H NMR (CDCl 3 ) δ 1.45 to 1.57 (m, 4H), 1.73 (quin, 2H), 1.85 (quin, 2H), 2.19 (s, 3H), 2. 34 (s, 3H), 4.06 (t, 2H), 4.18 (t, 2H), 5.82 (dd, 1H), 6.12 (dd, 1H), 6.41 (dd, 1H) ), 6.97 to 7.08 (m, 5H), 7.36 (d, 2H), 8.15 (d, 2H), 8.29 (d, 2H) ppm.
13 C NMR (CDCl 3 ) δ 16.1, 20.8, 25.6, 25.7, 28.5, 28.9, 64.4, 68.1, 114.3, 121.0, 121. 6,122.0,126.9,127.2,127.5,128.5,129.8,130.5,131.7,131.8,132.4,135.6,147.2 155.2, 163.7, 164.3, 164.3, 166.3 ppm.
LRMS (EI) m / z 516 (100).
(Comparative Example 20)
It is represented by formula (I-15) by the same method as in Example 15 except that a tetrahydrofuran solution in which a compound represented by formula (I-3-1) and triethylamine are mixed is added dropwise on the same scale as in Example 15. The resulting compound was prepared. The yield was 88% and the purity was 99.43%.
(Examples 16 to 25 and Comparative Examples 21 to 33) Evaluation of Films A matrix composition (M) comprising the following compound (A): 30%, compound (B): 40% and compound (C): 30% was prepared. did.

Figure 2013253041
Figure 2013253041

母体組成物(M)67.9%、本願発明の製造方法及び公知の製造方法によって製造した式(I−3)、式(I−4)、式(I−5)、式(I−6)、式(I−8)、式(I−9)、式(I−10)及び式(I−11)で表される化合物をそれぞれ29.1%及び光重合開始剤イルガキュア907(チバスペシャリティーケミカル社製)を3%含有する重合性組成物(N)を調整した。この重合性組成物(N)のシクロペンタノン溶液(重合性組成物(N)の濃度25%)を、ラビング処理したポリイミド付きガラスにスピンコート法で塗布し、65℃で3分乾燥した。得られた塗膜を60℃のホットプレート上に置き、紫外線を20mW/cmの強度で60秒間照射した。得られた重合体の外観及びイエローインデックス(YI)を評価した。目視によって重合体上にムラ等が無く全体に均一であれば◎、ムラが僅かに見られる場合には△、ムラが多く見られる場合は×とした。また、イエローインデックスはJASCO UV/VIS Spectrophotometer V−560で重合体の吸収スペクトルを測定し、付属のカラー診断プログラムで黄色度(YI)を計算した。YIは、
YI=100(1.28X−1.06Z)/Y (JIS K7373)
から算出した。
Maternal composition (M) 67.9%, formula (I-3), formula (I-4), formula (I-5), formula (I-6) produced by the production method of the present invention and known production methods ), Formula (I-8), Formula (I-9), Formula (I-10) and Formula (I-11), respectively, 29.1% of the compound and photopolymerization initiator Irgacure 907 (Ciba Specialty) A polymerizable composition (N) containing 3% of tea chemical was prepared. A cyclopentanone solution of the polymerizable composition (N) (concentration of the polymerizable composition (N) of 25%) was applied to glass with a rubbed polyimide by spin coating, and dried at 65 ° C. for 3 minutes. The obtained coating film was placed on a hot plate at 60 ° C. and irradiated with ultraviolet rays at an intensity of 20 mW / cm 2 for 60 seconds. The appearance and yellow index (YI) of the obtained polymer were evaluated. If there was no unevenness or the like on the polymer by visual observation, it was marked as ◎, when unevenness was found slightly, Δ, and when much unevenness was observed as x. As for the yellow index, the absorption spectrum of the polymer was measured with JASCO UV / VIS Spectrophotometer V-560, and the yellowness (YI) was calculated with the attached color diagnostic program. YI is
YI = 100 (1.28X-1.06Z) / Y (JIS K7373)
Calculated from

その後、得られた重合体を200℃で60分ポストベークした。ポストベーク後のYIについても同様に上記式より算出した。   Thereafter, the obtained polymer was post-baked at 200 ° C. for 60 minutes. Similarly, YI after post-baking was calculated from the above formula.

なお化合物(I−9)については、化合物そのものが黄色を呈しているため、YIの測定を行わなかった。また、比較例5において製造を検討した化合物(I−3)は、反応収率が低く単離が困難であったことから評価を行っていない。結果を下表に示す。   In addition, about the compound (I-9), since the compound itself is yellow, the measurement of YI was not performed. In addition, compound (I-3) whose production was examined in Comparative Example 5 was not evaluated because the reaction yield was low and isolation was difficult. The results are shown in the table below.

Figure 2013253041
Figure 2013253041

以上のように、本願発明の製造方法は高収率に目的化合物を得ることができた。また、製造時に生じる不純物含有量が少ないことも確認できた。不純物含有量が多くなるとそれを用いて重合体とした際にムラが生じ、またYIが悪化する。本願製造方法で得られた化合物を含有する重合性液晶組成物を用いて作製した重合体は、ムラが無く、重合後及びポストベーク後のイエローインデックスが十分低い値即ち、変色がほとんど起こらないことが分かった。このため本願発明の製造方法により製造される化合物は特にフィルムの用途に有用である。   As described above, the production method of the present invention was able to obtain the target compound in high yield. Moreover, it has also confirmed that the impurity content produced at the time of manufacture was small. When the impurity content is increased, unevenness occurs when the polymer is used, and YI deteriorates. The polymer produced using the polymerizable liquid crystal composition containing the compound obtained by the production method of the present application has no unevenness, and the yellow index after polymerization and after post-baking is sufficiently low, that is, almost no discoloration occurs. I understood. For this reason, the compound manufactured by the manufacturing method of this invention is especially useful for the use of a film.

Claims (11)

少なくとも一つのカルボキシル基を有する化合物(1)と、塩基(2)とを予め混合すること無く、酸ハロゲン化合物(3)に対し同時に加え反応させる混合酸無水物(4)の製造方法。   A method for producing a mixed acid anhydride (4), wherein the compound (1) having at least one carboxyl group and the base (2) are added and reacted simultaneously with the acid halogen compound (3) without being mixed in advance. 少なくとも一つのカルボキシル基を有する化合物(1)と、塩基(2)とを予め混合すること無く、酸ハロゲン化合物(3)に対し同時に加え反応させ混合酸無水物(4)とした後に、少なくとも一つのヒドロキシル基、メルカプト基及び/又はアミノ基から選ばれる基を有する化合物(5)を更に反応させるエステル化合物及び/又はアミド化合物(6)の製造方法。   The compound (1) having at least one carboxyl group and the base (2) are added to the acid halogen compound (3) at the same time without mixing in advance and reacted to form a mixed acid anhydride (4). A method for producing an ester compound and / or an amide compound (6), wherein a compound (5) having a group selected from two hydroxyl groups, mercapto groups and / or amino groups is further reacted. 少なくとも一つのカルボキシル基を有する化合物(1)が、芳香族カルボン酸又は脂肪族カルボン酸であることを特徴とする請求項1又は2記載の製造方法。   The production method according to claim 1 or 2, wherein the compound (1) having at least one carboxyl group is an aromatic carboxylic acid or an aliphatic carboxylic acid. 少なくとも一つのヒドロキシル基、メルカプト基及び/又はアミノ基から選ばれる基を有する化合物(5)が、アルコール類、フェノール類、チオール類、チオフェノール類、芳香族アミン及び/又は脂肪族アミンであることを特徴とする請求項1〜3のいずれか1項に記載の製造方法。   The compound (5) having a group selected from at least one hydroxyl group, mercapto group and / or amino group is an alcohol, a phenol, a thiol, a thiophenol, an aromatic amine and / or an aliphatic amine. The manufacturing method of any one of Claims 1-3 characterized by these. 酸ハロゲン化合物(3)が、スルホン酸ハロゲン化合物、カルボン酸ハロゲン化合物又はハロゲンギ酸エステル化合物であることを特徴とする請求項1〜4のいずれか1項に記載の製造方法。   The production method according to any one of claims 1 to 4, wherein the acid halogen compound (3) is a sulfonic acid halogen compound, a carboxylic acid halogen compound, or a halogen formate compound. 塩基(2)が、アミン、アミド、カルバメート、イミド、スルホンアミド、グアニジン、ヒドラゾン、ヒドラジド、ヒドラジン、複素環アミン、それらの塩、金属アルコキシド又は金属水酸化物であることを特徴とする請求項1〜5のいずれか1項に記載の製造方法。   The base (2) is an amine, amide, carbamate, imide, sulfonamide, guanidine, hydrazone, hydrazide, hydrazine, heterocyclic amine, salt thereof, metal alkoxide or metal hydroxide. The manufacturing method of any one of -5. 少なくとも一つのカルボキシル基を有する化合物(1)が、下記一般式(I)
Figure 2013253041
(式中、Gは下記式(i)
Figure 2013253041
(式中、Aは各々独立して1,4−フェニレン基、ナフタレン−2,6−ジイル基、1,4−シクロヘキシレン基、1,4−シクロヘキセニレン基、1,4−ビシクロ[2.2.2]オクチレン基、デカヒドロナフタレン−2,6−ジイル基、1,2,3,4−テトラヒドロナフタレン−2,6−ジイル基、ピリジン−2,6−ジイル基、ピリミジン−2,5−ジイル基、1,3−ジオキサン−2,5−ジイル基又は単結合を表すが、これらの基は無置換又は、各々独立してハロゲン、シアノ基、ニトロ基、ペンタフルオロスルフラニル基又は炭素原子数1から10のアルキル基によって置換されていても良いが、このアルキル基は各々独立して1個以上の水素原子がフッ素原子又は塩素原子により置き換えられても良く、このアルキル基上の1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CY=CY−又は−C≡C−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基、フッ素原子、塩素原子又はシアノ基を表す。)に置換されても良く、AはP−Sp−で表される基(式中、Pは下記の式(P−1)から式(P−17)
Figure 2013253041
から選ばれる基を表し、Spは1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CY=CY−又は−C≡C−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基、フッ素原子、塩素原子又はシアノ基を表す。)で置換されても良い炭素原子数1から20のアルキレン基又は単結合を表す。)によって置換されてもいても良く、Z11及びZ12は各々独立して−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CHCH−、−CHCF−、−CFCH−、−CFCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CY=CY−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基、フッ素原子、塩素原子又はシアノ基を表す。)、−C≡C−、−CH=N−、−N=CH−、−N=N−、−CH=N−N=CH−、炭素原子数1から20のアルキレン基又は単結合を表すが、このアルキレン基は各々独立して1個以上の水素原子がフッ素原子又は塩素原子により置き換えられても良く、このアルキレン基上の1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CY=CY−又は−C≡C−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基、フッ素原子、塩素原子又はシアノ基を表す。)に置き換えられても良く、m11は0から8の整数を表す。)を表し、R及びWは各々独立して水素原子、フッ素原子、塩素原子、臭素原子、ヨウ素原子、ペンタフルオロスルフラニル基、シアノ基、ニトロ基、炭素原子数1から20のアルキル基又はP−Sp−(式中、PはA中のPと同じ意味を表し、SpはAは中のSpと同じ意味を表す。ただし同一の基であっても異なる基であってもよい。)を表すが、このアルキル基は各々独立して1個以上の水素原子がフッ素原子又は塩素原子により置き換えられても良く、このアルキル基上の1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CY=CY−又は−C≡C−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基、フッ素原子、塩素原子又はシアノ基を表す。)に置き換えられても良いが、R及びWのうち少なくとも一方はカルボキシル基を表す。)で表される化合物である請求項1〜6のいずれか1項に記載の製造方法。
Compound (1) having at least one carboxyl group is represented by the following general formula (I)
Figure 2013253041
(In the formula, G 1 represents the following formula (i)
Figure 2013253041
(In the formula, each A 1 is independently 1,4-phenylene group, naphthalene-2,6-diyl group, 1,4-cyclohexylene group, 1,4-cyclohexenylene group, 1,4-bicyclo [ 2.2.2] Octylene group, decahydronaphthalene-2,6-diyl group, 1,2,3,4-tetrahydronaphthalene-2,6-diyl group, pyridine-2,6-diyl group, pyrimidine-2 , 5-diyl group, 1,3-dioxane-2,5-diyl group or a single bond, these groups are unsubstituted or each independently halogen, cyano group, nitro group, pentafluorosulfuranyl The alkyl group may be substituted by a group or an alkyl group having 1 to 10 carbon atoms, and each of these alkyl groups may be independently substituted with one or more hydrogen atoms by fluorine atoms or chlorine atoms. The above one —CH 2 — or two or more non-adjacent —CH 2 — are each independently —O—, —S—, —CO—, —COO—, —OCO—, —CO—. S-, -S-CO-, -O-CO-O-, -CO-NH-, -NH-CO-, -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH—, —OCO—CH═CH—, —CY═CY— or —C≡C— (wherein Y is independently a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom) Or A 1 represents a group represented by P-Sp- (wherein P represents the following formula (P-1) to formula (P-17)).
Figure 2013253041
And Sp represents one —CH 2 — or two or more non-adjacent —CH 2 — each independently —O—, —S—, —CO—, —COO—, -OCO-, -CO-S-, -S-CO-, -O-CO-O-, -CO-NH-, -NH-CO-, -CH = CH-COO-, -CH = CH-OCO -, -COO-CH = CH-, -OCO-CH = CH-, -CY = CY- or -C≡C- (wherein Y is independently a hydrogen atom, an alkyl having 1 to 12 carbon atoms) Represents a group, a fluorine atom, a chlorine atom or a cyano group.) Represents an alkylene group having 1 to 20 carbon atoms which may be substituted, or a single bond. Z 11 and Z 12 are each independently —O—, —S—, —OCH 2 —, —CH 2 O—, —CO—, —COO—, —OCO—. , -CO-S -, - S -CO -, - O-CO-O -, - CO-NH -, - NH-CO -, - SCH 2 -, - CH 2 S -, - CF 2 O-, -OCF 2 -, - CF 2 S -, - SCF 2 -, - CH 2 CH 2 -, - CH 2 CF 2 -, - CF 2 CH 2 -, - CF 2 CF 2 -, - CH = CH-COO -, - CH = CH-OCO -, - COO-CH = CH -, - OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 - COO -, - CH 2 CH 2 -OCO -, - COO-CH 2 -, - OCO-CH 2 -, - CH 2 -C O -, - CH 2 -OCO - , - CY = CY- ( wherein, Y each independently represent a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom or a cyano group.) , —C≡C—, —CH═N—, —N═CH—, —N═N—, —CH═N—N═CH—, an alkylene group having 1 to 20 carbon atoms or a single bond. In this alkylene group, one or more hydrogen atoms may each independently be replaced by a fluorine atom or a chlorine atom, and one —CH 2 — or two or more — CH 2 — is independently —O—, —S—, —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—CO—O—, —CO. -NH-, -NH-CO-, -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH—, —OCO—CH═CH—, —CY═CY— or —C≡C— (wherein Y is independently a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom) Or represents a cyano group.), And m11 represents an integer of 0 to 8. R 1 and W 1 each independently represent a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a pentafluorosulfuranyl group, a cyano group, a nitro group, or an alkyl having 1 to 20 carbon atoms. during group or P-Sp- (wherein, P is the same meaning as P in a 1, Sp is a 1 has the same meaning as Sp in. However there be the same group or different groups The alkyl groups each independently represent one or more hydrogen atoms replaced by fluorine or chlorine atoms, and one —CH 2 — or adjacent group on the alkyl group. Two or more —CH 2 — are each independently —O—, —S—, —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—. CO—O—, —CO—NH—, —NH—CO—, —CH═CH—COO—, CH═CH—OCO—, —COO—CH═CH—, —OCO—CH═CH—, —CY═CY— or —C≡C— (wherein Y is independently a hydrogen atom or carbon atom number) 1 to 12 represents an alkyl group, a fluorine atom, a chlorine atom or a cyano group.) At least one of R 1 and W 1 represents a carboxyl group. The manufacturing method of any one of Claims 1-6 which are the compounds represented by this.
少なくとも一つのヒドロキシル基、メルカプト基及び/又はアミノ基から選ばれる基を有する化合物(5)が、下記一般式(II)
Figure 2013253041
(式中、Gは下記式(ii)
Figure 2013253041
(式中、Aは各々独立して1,4−フェニレン基、ナフタレン−2,6−ジイル基、1,4−シクロヘキシレン基、1,4−シクロヘキセニレン基、1,4−ビシクロ[2.2.2]オクチレン基、デカヒドロナフタレン−2,6−ジイル基、1,2,3,4−テトラヒドロナフタレン−2,6−ジイル基、ピリジン−2,6−ジイル基、ピリミジン−2,5−ジイル基、1,3−ジオキサン−2,5−ジイル基又は単結合を表すが、これらの基は無置換又は、各々独立してハロゲン、シアノ基、ニトロ基、ペンタフルオロスルフラニル基又は炭素原子数1から10のアルキル基によって置換されていても良いが、このアルキル基は各々独立して1個以上の水素原子がフッ素原子又は塩素原子により置き換えられても良く、このアルキル基上の1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CY=CY−又は−C≡C−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基、フッ素原子、塩素原子又はシアノ基を表す。)に置き換えられても良く、AはP−Sp−(式中、PはA中のPと同じ意味を表し、SpはAは中のSpと同じ意味を表す。ただし同一の基であっても異なる基であってもよい。)で表される基によって置換されてもいても良く、Z21及びZ22は各々独立して−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CHCH−、−CHCF−、−CFCH−、−CFCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CY=CY−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基、フッ素原子、塩素原子又はシアノ基を表す。)、−C≡C−、−CH=N−、−N=CH−、−N=N−、−CH=N−N=CH−、炭素原子数1から20のアルキレン基又は単結合を表すが、このアルキレン基は各々独立して1個以上の水素原子がフッ素原子又は塩素原子により置き換えられても良く、このアルキレン基上の1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CY=CY−又は−C≡C−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基、フッ素原子、塩素原子又はシアノ基を表す。)に置き換えられても良く、m21は0から8の整数を表す。)を表し、R及びWは各々独立して水素原子、フッ素原子、塩素原子、臭素原子、ヨウ素原子、ペンタフルオロスルフラニル基、シアノ基、ニトロ基、炭素原子数1から20のアルキル基又はP−Sp−(式中、PはA中のPと同じ意味を表し、SpはAは中のSpと同じ意味を表す。ただし同一の基であっても異なる基であってもよい。)を表すが、このアルキル基は各々独立して1個以上の水素原子がフッ素原子又は塩素原子により置き換えられても良く、このアルキル基上の1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CY=CY−又は−C≡C−(式中、Yは各々独立して水素原子、炭素原子数1から12のアルキル基、フッ素原子、塩素原子又はシアノ基を表す。)で置換されても良いが、R及びWのうち少なくとも一方はヒドロキシル基、メルカプト基及び/又はアミノ基から選ばれる基を表す。)で表される化合物である請求項1から請求項7記載の製造方法。
The compound (5) having a group selected from at least one hydroxyl group, mercapto group and / or amino group is represented by the following general formula (II):
Figure 2013253041
(In the formula, G 2 represents the following formula (ii)
Figure 2013253041
(In the formula, each A 2 is independently 1,4-phenylene group, naphthalene-2,6-diyl group, 1,4-cyclohexylene group, 1,4-cyclohexenylene group, 1,4-bicyclo [ 2.2.2] Octylene group, decahydronaphthalene-2,6-diyl group, 1,2,3,4-tetrahydronaphthalene-2,6-diyl group, pyridine-2,6-diyl group, pyrimidine-2 , 5-diyl group, 1,3-dioxane-2,5-diyl group or a single bond, these groups are unsubstituted or each independently halogen, cyano group, nitro group, pentafluorosulfuranyl The alkyl group may be substituted by a group or an alkyl group having 1 to 10 carbon atoms, and each of these alkyl groups may be independently substituted with one or more hydrogen atoms by fluorine atoms or chlorine atoms. The above one —CH 2 — or two or more non-adjacent —CH 2 — are each independently —O—, —S—, —CO—, —COO—, —OCO—, —CO—. S-, -S-CO-, -O-CO-O-, -CO-NH-, -NH-CO-, -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH—, —OCO—CH═CH—, —CY═CY— or —C≡C— (wherein Y is independently a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom) or a cyano group.) may be replaced by, a 2 is in the P-Sp- (wherein, P is the same meaning as P in a 1, Sp is the same meaning as Sp in the a 1 represents. However may be either the same group different group.) it may be had be substituted by a group represented by, Z 21 and Z 2 Each independently -O is -, - S -, - OCH 2 -, - CH 2 O -, - CO -, - COO -, - OCO -, - CO-S -, - S-CO -, - O -CO-O -, - CO- NH -, - NH-CO -, - SCH 2 -, - CH 2 S -, - CF 2 O -, - OCF 2 -, - CF 2 S -, - SCF 2 - , —CH 2 CH 2 —, —CH 2 CF 2 —, —CF 2 CH 2 —, —CF 2 CF 2 —, —CH═CH—COO—, —CH═CH—OCO—, —COO—CH═ CH -, - OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO- CH 2 -, - OCO-CH 2 -, - CH 2 -COO -, - CH 2 -OCO -, - CY = CY- ( wherein, Y each independently represents a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom or a cyano group. ), —C≡C—, —CH═N—, —N═CH—, —N═N—, —CH═N—N═CH—, an alkylene group having 1 to 20 carbon atoms or a single bond. Each of the alkylene groups independently may have one or more hydrogen atoms replaced by fluorine or chlorine atoms, and one —CH 2 — or two or more non-adjacent ones on the alkylene group. —CH 2 — is independently —O—, —S—, —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—CO—O—, — CO-NH-, -NH-CO-, -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH-, -OCO-CH = CH-, -CY = CY- or- C≡C— (wherein Y is independently a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom, Represents a cyano group), and m21 represents an integer of 0 to 8. R 2 and W 2 each independently represent a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a pentafluorosulfuranyl group, a cyano group, a nitro group, or an alkyl having 1 to 20 carbon atoms. during group or P-Sp- (wherein, P is the same meaning as P in a 1, Sp is a 1 has the same meaning as Sp in. However there be the same group or different groups The alkyl groups each independently represent one or more hydrogen atoms replaced by fluorine or chlorine atoms, and one —CH 2 — or adjacent group on the alkyl group. Two or more —CH 2 — are each independently —O—, —S—, —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—. CO—O—, —CO—NH—, —NH—CO—, —CH═CH—COO—, CH═CH—OCO—, —COO—CH═CH—, —OCO—CH═CH—, —CY═CY— or —C≡C— (wherein Y is independently a hydrogen atom or carbon atom number) Represents an alkyl group of 1 to 12, a fluorine atom, a chlorine atom or a cyano group.), But at least one of R 2 and W 2 is selected from a hydroxyl group, a mercapto group and / or an amino group. Represents a group. The production method according to claim 1, wherein the compound is represented by the formula:
請求項1から請求項8のいずれかに記載の製造方法により製造した化合物を含有する医薬品、農薬、液晶材料、ポリマー、樹脂、顔料、染料、化粧品、食品、インキ、粘着剤、接着剤、印刷物、光学異方体、表示素子又は電子デバイス。   Pharmaceuticals, agricultural chemicals, liquid crystal materials, polymers, resins, pigments, dyes, cosmetics, foods, inks, pressure-sensitive adhesives, adhesives, printed matter containing the compound produced by the production method according to any one of claims 1 to 8. , Optical anisotropic bodies, display elements or electronic devices. 請求項1から請求項8のいずれかに記載の製造方法により製造した化合物を中間体として製造される化合物。   The compound manufactured by using the compound manufactured by the manufacturing method in any one of Claims 1-8 as an intermediate body. 請求項10に記載の化合物を含有する医薬品、農薬、液晶材料、ポリマー、樹脂、顔料、染料、化粧品、食品、インキ、粘着剤、接着剤、印刷物、光学異方体、表示素子又は電子デバイス。   Pharmaceuticals, agricultural chemicals, liquid crystal materials, polymers, resins, pigments, dyes, cosmetics, foods, inks, adhesives, adhesives, printed materials, optical anisotropic bodies, display elements or electronic devices containing the compound according to claim 10.
JP2012129727A 2012-06-07 2012-06-07 Method for producing compound Active JP5988087B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2012129727A JP5988087B2 (en) 2012-06-07 2012-06-07 Method for producing compound
KR1020130064450A KR20130137548A (en) 2012-06-07 2013-06-05 Method for producing compound
CN201310224992.1A CN103483117B (en) 2012-06-07 2013-06-07 The manufacture method of compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012129727A JP5988087B2 (en) 2012-06-07 2012-06-07 Method for producing compound

Publications (2)

Publication Number Publication Date
JP2013253041A true JP2013253041A (en) 2013-12-19
JP5988087B2 JP5988087B2 (en) 2016-09-07

Family

ID=49823780

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012129727A Active JP5988087B2 (en) 2012-06-07 2012-06-07 Method for producing compound

Country Status (3)

Country Link
JP (1) JP5988087B2 (en)
KR (1) KR20130137548A (en)
CN (1) CN103483117B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018003514A1 (en) * 2016-06-28 2018-01-04 Dic株式会社 Polymerizable liquid crystal composition
WO2020022422A1 (en) * 2018-07-25 2020-01-30 富士フイルム株式会社 Polymerizable liquid crystal composition, optically anisotropic film, optical film, polarizing plate, and image display device

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017154588A1 (en) * 2016-03-10 2017-09-14 Dic株式会社 Method for producing compound having ester group
US20210130393A1 (en) * 2018-06-15 2021-05-06 Yokogawa Electric Corporation Method for producing amide

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000505100A (en) * 1996-09-10 2000-04-25 ドクトル カルル トーマエ ゲゼルシャフト ミット ベシュレンクテル ハフツング Modified amino acids, drugs containing these compounds and methods for their preparation
JP2002053543A (en) * 2000-06-02 2002-02-19 Sumitomo Chem Co Ltd Method for producing mixed acid anhydride and method for producing amide compound with the same
JP2007039345A (en) * 2005-08-01 2007-02-15 Sumitomo Chemical Co Ltd Method for producing mixed acid anhydride
WO2007052517A1 (en) * 2005-10-31 2007-05-10 Sumitomo Chemical Company, Limited Method for producing hydroxy-2-pyrrolidinecarboxyamide compound
JP2007126400A (en) * 2005-11-04 2007-05-24 Sumitomo Chemical Co Ltd Method for producing amide compound using mixed acid anhydride

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09104642A (en) * 1995-10-11 1997-04-22 Fuji Photo Film Co Ltd Production of mixed acid anhydride
US6753431B2 (en) * 2000-06-02 2004-06-22 Sumitomo Chemical Company Limited Production of mixed acid anhydride and amide compound

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000505100A (en) * 1996-09-10 2000-04-25 ドクトル カルル トーマエ ゲゼルシャフト ミット ベシュレンクテル ハフツング Modified amino acids, drugs containing these compounds and methods for their preparation
JP2002053543A (en) * 2000-06-02 2002-02-19 Sumitomo Chem Co Ltd Method for producing mixed acid anhydride and method for producing amide compound with the same
JP2007039345A (en) * 2005-08-01 2007-02-15 Sumitomo Chemical Co Ltd Method for producing mixed acid anhydride
WO2007052517A1 (en) * 2005-10-31 2007-05-10 Sumitomo Chemical Company, Limited Method for producing hydroxy-2-pyrrolidinecarboxyamide compound
JP2007126400A (en) * 2005-11-04 2007-05-24 Sumitomo Chemical Co Ltd Method for producing amide compound using mixed acid anhydride

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6016026727; Keller, P. A.: Science of Synthesis Vol.20a, 2006, p.617-641 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018003514A1 (en) * 2016-06-28 2018-01-04 Dic株式会社 Polymerizable liquid crystal composition
JP6414367B2 (en) * 2016-06-28 2018-10-31 Dic株式会社 Polymerizable liquid crystal composition
JPWO2018003514A1 (en) * 2016-06-28 2018-12-27 Dic株式会社 Polymerizable liquid crystal composition
WO2020022422A1 (en) * 2018-07-25 2020-01-30 富士フイルム株式会社 Polymerizable liquid crystal composition, optically anisotropic film, optical film, polarizing plate, and image display device
JPWO2020022422A1 (en) * 2018-07-25 2021-08-12 富士フイルム株式会社 Polymerizable liquid crystal composition, optically anisotropic film, optical film, polarizing plate and image display device
JP7118153B2 (en) 2018-07-25 2022-08-15 富士フイルム株式会社 Polymerizable liquid crystal composition, optically anisotropic film, optical film, polarizing plate and image display device
US11746295B2 (en) 2018-07-25 2023-09-05 Fujifilm Corporation Polymerizable liquid crystal composition, optically anisotropic film, optical film, polarizing plate, and image display device

Also Published As

Publication number Publication date
KR20130137548A (en) 2013-12-17
CN103483117B (en) 2018-04-24
CN103483117A (en) 2014-01-01
JP5988087B2 (en) 2016-09-07

Similar Documents

Publication Publication Date Title
TWI395732B (en) Novel polymerizable compounds
JP6066252B2 (en) Polymerizable compound and optical anisotropic body
JP5754078B2 (en) Compound
TWI465552B (en) A polymerizable liquid crystal compound, a polymerizable liquid crystal composition, a liquid crystalline polymer, and an optical anisotropy
KR101084675B1 (en) Radial-shaped liquid crystal compound and optical film and liquid crystal display device comprising the same
TWI526457B (en) Polymerizable compound having lateral substituent on an ending ring structure
US8067068B2 (en) Liquid crystal compositions
JP6241654B2 (en) Polymerizable compound and optical anisotropic body
JP5888544B2 (en) Polymerizable liquid crystal compound
US20110186777A1 (en) Polymerizable chiral compound, polymerizable liquid crystal composition, liquid crystal polymer and optically anisotropic body
JP2016017034A (en) Polymerizable compound and optical anisotropic body
JP5988087B2 (en) Method for producing compound
JP6596928B2 (en) Carboxylic acid compound, method for producing the same, and liquid crystal composition using the compound
US11959005B2 (en) Liquid crystal compounds
CN102791749B (en) Polymerizable chiral compound, polymerizable liquid crystal compound, liquid crystal liquid crystal property polymer and optically anisotropic body
US8044228B2 (en) Liquid crystal compositions
EP2687517B1 (en) Polymerizable compound, polymerizable liquid crystalline composition, macromolecular compound and film
US20220251450A1 (en) New polymerizable liquid crystal having a quinoxaline-hydrazone core
US20120071618A1 (en) Liquid crystal compositions
US20130188120A1 (en) Compound having photosensitivity, polymer formed by polymerizing the compound, and production method thereof
WO2024068311A1 (en) Liquid crystal compounds
JP2014019654A (en) Polymerizable acetylene compound

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150401

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20150819

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150910

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150928

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160301

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160330

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160714

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160727

R151 Written notification of patent or utility model registration

Ref document number: 5988087

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R154 Certificate of patent or utility model (reissue)

Free format text: JAPANESE INTERMEDIATE CODE: R154